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Abstract 
 
Background: Evidence from effectiveness studies suggests that Acceptance and 
Commitment Therapy (ACT) is effective in reducing distress associated with clinical 
disorders through targeting the processes associated with experiential avoidance 
and psychological inflexibility as opposed to directly targeting the symptoms of 
clinical disorders.  
Objective: This systematic review aimed to synthesize the peer-reviewed evidence 
for the effect of ACT interventions on depression and anxiety in clinical populations. 
Method: Research literature published between 2000-2011 was searched and the 
results were screened against inclusion criteria to identify ACT interventions that 
measured depression and anxiety outcomes in clinical samples. Thirteen studies 
were identified as suitable for inclusion in the review, including trials comparing ACT 
interventions with waiting lists/control groups, and trials comparing ACT with other 
active treatments.   
Results/Conclusions: The randomised control trials (RCTs) reviewed indicated that 
ACT intervention demonstrated within group effectiveness for reducing depression 
and anxiety and improving psychological flexibility across clinical samples. The 
review revealed that, relative to treatment as usual an ACT approach is effective with 
clinical populations experiencing affective symptoms within the more moderate to 
severe range, as well as those presenting with mild levels of depression and anxiety. 
However, the effectiveness of ACT compared to other active treatments is less 
pronounced. 
Key Words: Acceptance and Commitment Therapy; Acceptance-based therapy, 
Depression; Anxiety 
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Introduction 
Acceptance and Commitment Therapy (ACT) is based on behavioural principles 
grounded in Functional Contextualism and Relational Frame Theory (Hayes et al. 
2001). Functional contextualism posits that behaviour can be explained in terms of 
contextual variables and therefore thoughts and feelings do not directly cause other 
actions (Ruiz, 2010). Therefore in ACT, cognitive experiences are not appraised as 
being correct or erroneous but are viewed as functional and useful experiences.  
ACT is also informed by Relational Frame Theory (RFT). RFT is used to explain the 
origins of verbal abilities and their expansion into human language and cognition 
(see Luoma et al. 2007). This has implications for human experience and distress 
as relational associations are often verbally acquired and not based on direct 
experience. For example, imagine a young child who hears that she is going on a 
"bus", and subsequently experiences travel sickness (the word "bus" becomes 
aversive). The child may then learn at school that a "coach" is a type of bus. Later, 
on hearing that she is going on a coach, the child may show signs of anxiety 
despite having had no direct experience of being on a coach. This effect is based 
on the acquired relation between "bus" and "coach". The child does not need to 
experience the possible aversive consequences of going on a coach in order to 
experience anxiety. This conceptualisation of relational networks suggests that 
through behavioural change it is possible to directly change the context of relational 
associations without changing their content.  
ACT Principles 
Although ACT acknowledges that specific pathological process are associated with 
particular disorders, it posits that general processes to attempt to control, suppress 
or alter forms of internal experiences occur across human experience causing 
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behavioural harm (Luoma et al. 2007). This concept is described as psychological 
inflexibility. Psychological inflexibility describes active or passive attempts to avoid 
and/or escape private experiences such as affects, thoughts, memories and bodily 
sensations which are experienced as aversive (Hayes et al. 2006).  
The principle aim of ACT is to engage in positive behaviours rather than attempting 
to avoid difficult internal experiences. ACT seeks to generate psychological flexibility 
by developing skills associated with being in contact with the present moment as a 
fully conscious human being and persisting in behaviour that serves valued ends 
(Hayes et al. 2006). According to Gloster et al. (2011), psychological flexibility is a 
broad, higher level construct, used to capture several core, interconnected 
processes. Indeed, ACT seeks to increase psychological flexibility by targeting six 
major processes: 
1. Acceptance: The process of acceptance describes one’s willingness to 
contact feared inner experiences; an alternative to experiential avoidance. 
Willingness to accept is explored through the development of creative 
hopelessness which refers to a person’s exploration of the short and long 
term effects of their current actions.  
2. Being Present: Refers to the ongoing, non-judgemental contact with 
psychological and environmental events as they occur. 
3. Defusion: The process of defusion aims to develop skills in experiencing and 
observing thoughts, memories and sensations allowing the person to become 
aware of their experiences without becoming entangled in them.  
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4. Self as context: The process of self as context is explored through practice in 
experiencing oneself within the context in which inner experiences occur 
rather than being defined by the content.  The process of being present refers 
to the ability to flexibly attend to and notice inner experiences as they occur 
without judgement.  
5. Values: ACT places specific emphasis on individuals exploring what it is that 
they value in life.  
6. Committed action: psychological and behavioural flexibility is promoted when 
individuals engage in committed action that is consistent with them moving 
towards valued directions.  
These core processes are both overlapping and interrelated, each supporting 
psychological flexibility and behaviour change (Luoma et al. 2007). Therefore, ACT 
is not focussed on the reduction of discomfort but in allowing oneself to behave in a 
valued way in the presence of this discomfort (Ruiz, 2010).  
The application of ACT in clinical populations 
There is evidence for the effectiveness of ACT in the treatment of a spectrum of 
clinical disorders including depression and anxiety (Bohlmeijer et al. 2011; Forman et 
al. 2007), obsessive compulsive disorder (Twohig et al. 2010), self harm (Gratz & 
Gunderson, 2006), chronic pain disorders (Wetherell et al. 2011; Wicksell et al. 
2008), substance use (Hayes et al. 2004; Smout et al. 2010) and psychosis (White et 
al. 2011; Gaudiano & Herbert, 2006; Bach & Hayes, 2002). Many of these studies 
investigated depression and anxiety symptoms as primary or secondary outcomes. 
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Some studies reported medium to large effect sizes on the reduction of depression 
and anxiety symptoms (Forman et al. 2007: Lappalainen et al. 2007).  
Empirical reviews of ACT 
Hayes et al (2006) provided a review of correlational studies exploring experiential 
avoidance in pathology as well as findings from randomised controlled trials (RCTs). 
Over 20 RCTs were reported as superior to control, wait-list or other structured 
intervention.  Effect sizes were reported as generally larger with more severe 
problems, and were as large or larger at follow-up than immediately post-
intervention. Ost (2008) reviewed 13 RCTs using ACT reporting moderate effect 
sizes compared to controls and treatment as usual. Ost (2008) also directly 
compared the efficacy of ACT compared to CBT by selecting a comparable study for 
each RCT that was published within the same journal that year. Ost (2008) reported 
that ACT studies had lower scores on methodology and moderate effect sizes. Ost 
(2008) concluded that none of the third wave therapies reviewed at that time fulfilled 
criteria for an empirically supported treatment. Gaudiano (2009) responded to Ost’s 
(2008) findings with a re-analysis of the review. According to Gaudiano (2009), the 
ACT and CBT studies compared were mismatched in terms of populations studied 
and differences in design methodology.  For example, a majority of the ACT studies 
were conducted in ‘difficult-to-treat’ and ‘treatment resistant’ populations whereas the 
CBT trials were studies of emotional disorders. Gaudiano (2009) proposed that these 
methodological issues limited Ost’s (2008) findings and conclusions. 
 
Powers et al. (2009) conducted a meta-analytic review of ACT in randomised clinical 
trials (RCTs). This review concluded that of the 18 RCTs reviewed, ACT was 
superior in effect size to: control treatments, waiting list and treatment as usual, but 
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not significantly better than other established treatments and was not superior to 
control treatments in depression and anxiety populations. However, Levin and Hayes 
(2009) conducted a re-analysis of Powers et al.’s (2009) data following claims of 
discrepancy in the classification of the treatment as usual groupings. This re-analysis 
concluded that ACT was superior to established treatments. Most recently, Ruiz 
(2010) conducted a review of the correlational, experimental and outcome studies 
using ACT. Difficulties with psychological flexibility, as measured by the Acceptance 
and Action Questionnaire (AAQ-I Hayes et al. 2004; AAQ-II Bond et al. 2011) were 
correlated with a wide range of psychological disorders. Further, in experimental 
studies, acceptance-based protocols were reported as more efficacious than control 
based protocols. When considering the outcome studies, Ruiz (2010) reports that 
ACT is efficacious across a wide range of problems and that effect sizes are typically 
large and even better at follow up. Ruiz (2010) proposes that further, better 
controlled studies, with larger samples are required to effectively compare the 
efficacy of ACT with CBT.  
 
To summarise, there appears to be growing evidence regarding the empirical status 
of ACT. However, the reliability of this evidence has been debated in the literature, 
with discrepancies over the investigative methodologies undertaken. Indeed, many 
of the re-analyses have been conducted by authors integral to the development of 
ACT and many of the reviews exploring ACT have examined disparate populations. 
Consistent in the findings is that ACT is superior to control, wait list and treatment as 
usual conditions; however, more evidence is required to determine if ACT is superior 
to other established treatments. The above findings afford the rationale for 
conducting a review that seeks to isolate RCTs investigating the effectiveness of 
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ACT upon particular psychological symptoms of distress, in order to synthesize the 
findings in a more comprehensive manner.  Therefore, this systematic review 
explores the effectiveness of ACT in reducing distress associated with two particular 
forms of psychopathology namely depression and anxiety across clinical 
populations.  A similar meta-analytic review has been conducted by Hoffman et al. 
(2010) examining the effectiveness of mindfulness-based therapy (MBT) on anxiety 
and depression. In this review, studies in which the mindfulness intervention was 
coupled with ACT principles were excluded. The results of this review suggest that 
MBT improved symptoms of anxiety and depression across a relatively wide range of 
disorders and severities. 
 
Objectives 
This systematic review aims to evaluate and synthesize current published peer-
reviewed RCTs examining the effects of ACT on depression and anxiety in clinical 
populations. The review will also provide an opportunity to reflect on how research 
into the effectiveness of ACT for depression and anxiety can be improved in the 
future. 
 
Method 
Search 
Studies were identified by searching  
 CINAHL,  
 MEDLINE,  
 PsychInfo and  
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 Psychology and Behavioural Sciences Collection.  
Searches were conducted for studies published in English between the 1st January 
2000 and the 7th of October 2011.  The following search criteria were used to 
conduct the literature search: Random or randomly or randomize or randomise or 
randomized or randomised or (clinical trial) or trial combined with (acceptance 
and commitment therapy) or (acceptance-based) combined with anxi* or 
depress*. Searching of the reference lists of identified articles was also conducted. 
Additionally a review of RCTs conducted in ACT published on the Association of 
Contextual and Behavioural Sciences website was also conducted.  
Eligibility 
Studies were eligible for inclusion if they:  
(1) used an ACT intervention,  
(2) included a clinical population (patients had a diagnosable psychological or 
medical disorder) 
(3) used an adult sample,  
(4) were randomised and  
(5) used a standardised measure of mood and/or anxiety pre and post intervention.  
 
Studies were excluded if the ACT intervention was delivered along with another 
intervention (e.g., cognitive therapy), if the intervention was not delivered face-to-
face by a therapist or if the study employed a qualitative methodology. Studies were 
not eligible for inclusion if they were not published in a peer-reviewed publication, for 
example, conference abstracts, book chapters and dissertations. 
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Quality assessment 
A methodological quality rating scale was developed by the author (see Appendix 
1.1). The studies were rated against a checklist, based on CONSORT guidelines, on 
study design, methodology, description of intervention and appropriate reporting of 
results. The higher the score the greater the methodology quality of the RCT. The 
quality rating of the studies was conducted by the author and an independent 
reviewer. Agreement on each of the individual item scores between the two raters 
reached 98.6%. Disagreement was resolved and 100% agreement was reached 
(See Appendix 1.1 for a matrix of the quality rating scores of the included studies). 
 
Effect Size Analysis 
Where possible, effect sizes for measures of depression, anxiety and psychological 
flexibility were reported or calculated from the data set. Effect sizes for group 
differences were transformed using Cohen’s d. Reporting of effect size magnitude is 
consistent with Cohen (1988), where an effect size of d= 0.2 to 0.3 is considered a 
"small" effect, around 0.5 a "medium" effect and 0.8 upwards a "large" effect. 
 
Pre-treatment severity of depression and anxiety 
If individuals were not presenting with clinically important levels of depression and 
anxiety, there may be a risk of so-called ‘flooring effects’ where it is not possible to 
detect whether the ACT intervention potentially had a positive impact on depression 
and/or anxiety scores. Therefore, reported pre-treatment symptom severity, as 
assessed by the outcome measures utilised by the trials, were examined. In order to 
assess whether the symptoms of anxiety or depression were at a clinically important 
level at baseline, mean scores on the outcomes measures were compared against 
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the recommended cut off scores for differentiating levels of severity on outcome 
measure. For the purposes of this review clinically important levels of anxiety and 
depression are considered to be mean scores above the cut-off for mild depression 
and anxiety on the various scales used. For example, for the Hospital Anxiety and 
Depression Scale (HADS) a score of eight or above for each subscale was adopted, 
as recommended by the authors (Zigmond & Snaith, 1983). Only those studies in 
which the mean sample score indicated clinical (≥ mild) levels of anxiety or 
depression at baseline were included in the synthesis of effect sizes. See Appendix 
1.2 for a summary of outcome measures and scoring recommended by the authors.  
 
Results 
Study characteristics 
A flow diagram of the study selection process is outlined in Figure 1. Of the 62 
studies identified through database searching and five studies identified through 
other sources, 13 met the inclusion criteria. Table 1 provides details about the 
included studies. The clinical populations investigated were psychosis (Gaudiano & 
Herbert, 2006; White et al. 2011), chronic pain (Wetherell et al. 2011; Wicksell et al. 
2008), substance use (Hayes et al. 2004; Smout et al. 2010), depression (Bohlmeijer 
et al. 2011), depression and anxiety (Forman et al. 2007), depression and alcohol 
(Petersen & Zettle, 2009), obsessive compulsive disorder (Twohig et al. 2010), 
deliberate self harm in borderline personality disorder (Gratz & Gunderson, 2006), 
tinnitus (Westin et al. 2011) and mental health disorders, including depression, 
anxiety, sleep disorders and OCD (Lappalainen et al. 2007). The studies represent a 
total sample of n=826; of which the mean age of participants was 39 years of age 
(SD = 7.71 years). Data were available on depression outcomes for all 826 
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participants, on anxiety outcomes for 560 participants and on psychological flexibility 
outcomes for 572 participants. The studies reviewed report interventions ranging 
from eight to 32 sessions in group based and one-to-one formats (see Table 1). 
 
[INSERT FIGURE 1 NEAR HERE] 
 
[INSERT TABLE 1 NEAR HERE] 
 
Measurement of Psychological flexibility 
A total of ten of the 13 studies measured psychological flexibility; traditionally a key 
outcome variable in ACT research. The Acceptance and Action Questionnaire 
(variously developed by Steven Hayes, Frank Bond and colleagues) was used in 
seven studies. The AAQ is designed to evaluate the extent to which an individual 
exhibits psychological flexibility; which comprises the ability to fully contact the 
present moment and the thoughts and feelings it contains whilst changing behaviour 
in the pursuit of goals and values (Hayes et al. 2006). This self report measure first 
developed by Hayes et al. (2006) has several versions and revisions ranging from a 
seven-item to 49-item version. Four studies used the AAQ-I 9-item version (Petersen 
& Zettle, 2009; Forman et al. 2007; Gratz & Gunderson, 2006; Lappalainen et al. 
2007), one study used the AAQ-I 16-item version (Twohig et al. 2010) and two 
studies used the AAQ-II 10 item version (White et al. 2011; Bohlmeijer et al. 2011). 
The Psychological Inflexibility in Pain Scale (PIPS) was administered in one study 
(Wicksell et al. 2008). This 16-item questionnaire requires the self rating of how true 
a statement is on a seven-point Likert scale in order to assess psychological 
inflexibility in relation to pain. The Chronic Pain Acceptance Questionnaire-Revised 
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(CPAQ-R) (McCracken et al. 2004) was administered in one of the studies 
(Wetherell et al. 2011). The CPAQ-R is a pain acceptance measure in which 20-
items, self rated on a Likert scale, are used to measure the degree to which an 
individual has adjusted to pain as part of their identity and lifestyle. Finally, the 
Tinnitus Acceptance Questionnaire (TAQ) (Westin et al. 2008) is a measure of 
experiential avoidance in relation to Tinnitus. The measure consists of twelve items 
that are self rated and was used by one study (Westin et al. 2011).  
 
Measurement of depression and levels at baseline 
A total of 13 studies measured depression. Five studies (Twohig et al. 2010; 
Petersen & Zettle, 2009; Forman et al. 2007; Wetherell et al. 2011; Smout et al. 
2010) used the Beck Depression Inventory second edition (Beck, Steer & Brown, 
1996) and two studies (Lappalainen et al. 2007; Hayes et al. 2004) used the Beck 
Depression inventory first edition (Beck et al. 1961). The BDI and BDI-II are self 
report measures composed of 21 questions or items, each with four possible 
responses. Each response is assigned a score ranging from zero to three, indicating 
the severity of the symptom. Three studies (Wicksell et al. 2008; White et al. 2011; 
Westin et al. 2011) used the Hospital Anxiety and Depression Scale (HADS) 
(Zigmond & Snaith, 1983), the HADS consists of 14 items, divided into two, seven-
item subscales: Anxiety (HADS-A) and Depression (HADS-D). The respondent rates 
each item on a four-point scale. Petersen and Zettle (2009) used the Hamilton 
Rating Scale (HRS) (Hamilton, 1960), a 21-item clinician rated measure of 
depressive symptoms. Bohlmeijer et al. (2011) used the Centre for Epidemiological 
Studies Depression Scale (CES-D) (Radloff, 1977), a 20-item questionnaire that 
measures depressive symptoms in the general population. Gratz and Gundersen 
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(2006) used the 21-item version of the Depression Anxiety Stress Scales (DASS) 
(Lovibond & Lovibond, 1995b). This measure provides separate scores of 
depression, anxiety and stress. Finally, the Brief Psychiatric Rating Scale - Affect 
Subscale (Overall & Gorham, 1962) was used by one study (Gaudiano & Herbert, 
2006). This is a structured clinical interview whereby the affect subscales include 
anxiety, guilt, depression and somatic symptoms.  
There were a range of levels of depression reported at baseline: The Tinnitus 
sample examined by Westin et al. (2011) did not report clinically important levels of 
depression at baseline. Eight studies included samples that identified mean 
depression scores indicating mild depressive symptoms, namely Twohig et al. 
(2010); Wicksell et al. (2008); Wetherell et al. (2011); Forman et al. (2007); Gratz 
and Gunderson (2006); Lappalainen et al. (2007); Hayes et al. (2004) and White et 
al. (2011).  Three studies included samples with mean depression scores that 
indicated moderate to severe depressive symptoms at baseline, namely Bohlmeijer 
et al. (2011); Petersen and Zettle (2009) and Smout et al. (2010). (See Appendix 
1.2.). 
Measurement of anxiety and levels at baseline 
A total of nine studies measured anxiety symptoms. The Hospital Anxiety and 
Depression Scale (HADS) (Zigmond & Snaith, 1983) anxiety subscales were used in 
four studies (Bohlmeijer et al. 2011; Wicksell et al. 2008; White et al. 2011; Westin et 
al. 2011). Another study (Gratz & Gunderson, 2006) utilised the Depression Anxiety 
Stress Scales (DASS) (Lovibond & Lovibond, 1995b). The Pain Anxiety Symptoms 
Scale-Short Form (McCracken & Dhingra, 2007) was also used by Wetherell et al. 
(2011). This 20-item scale measures fear and anxiety responses specific to pain.  
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One study (Twohig et al. 2010) used the Yale Brown Obsessive Compulsive Scale 
(Goodman et al, 1989); this consists of an assessor rated measure of symptom 
severity associated with OCD.  
Levels of anxiety reported at baseline ranged from minimal anxiety to severe. The 
Tinnitus sample examined by Westin et al. (2011) did not report clinically important 
symptoms of anxiety at baseline. Four studies included samples that identified mean 
anxiety scores indicating mild symptoms, namely Bohlmeijer et al. (2011); Wicksell et 
al. (2008); Forman et al. (2007) and White et al. (2011).  Gratz and Gunderson 
(2006) included a sample with a mean anxiety score that indicated moderate 
symptoms at baseline while Twohig et al. (2010) identified a severe mean level of 
reported anxiety at baseline (See Appendix 1.2).  
 
Methodological quality and effect size 
The methodological quality rating scores varied across the 13 studies from 32 to 50 
out of a possible total score of 65, (Median= 41, IQR= 9). This highlights a 
distribution of methodological quality of the studies included in the review. The 
common areas in which methodological quality scores were lower included non-
reporting of descriptive analyses comparing participants with those who had dropped 
out as well as failure to report how possible deviations from the therapy protocol 
would be identified. Furthermore, some studies did not state if power calculations 
were conducted to determine sample size.  Those studies with high quality rating 
scores (White et al. 2011; Twohig et al. 2010; Westin et al. 2011) provided details of 
the process of randomisation sequencing and allocation in the methodology and the 
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process of blinding to group assignment was made clear. In total six out of the 13 
studies (46%) reported the use of blinding to group assignment.  
  
Effects on depression following intervention 
RCTs comparing ACT with another active treatment 
Twohig et al. (2010) examined an OCD sample (n=79) and reported a medium effect 
size (d= .63) in the reduction in depression from baseline to 3-month follow up 
compared to Progressive Relaxation Training (PRT) and a large effect size (d=1.52) 
within ACT from baseline to 3-month follow up. Only those measured to be “at least 
mildly depressed” (BDI-II score of 13 or above) were included in the analysis (see 
Table 2). Forman et al. (2007) examined a sample reporting depression and/or 
anxiety symptoms (n=101) comparing ACT with CBT. The mean depression score at 
baseline, as measured by the BDI-II, was 19 indicating the sample met the criteria 
for mild to moderate depression at baseline. No significant differences were reported 
between the groups (p=.837, d=.00) and a medium effect size (d=.65) was reported 
when considering the reduction in depression within the ACT intervention group (see 
Table 2). Lappalainen et al. (2007) investigated the effectiveness of ACT and CBT in 
an out-patient primary care population reporting mild to moderate mental health 
difficulties (n=28). The mean score on the BDI at baseline within the ACT group was 
14, indicating reporting of symptoms associated with mild depression at baseline. 
They reported large effect sizes within the ACT intervention group in the reduction of 
depressive symptoms (d=.83). Between group effect sizes revealed medium size 
differences in favour of ACT compared to CBT (d=.53) post intervention. However, 
the study was underpowered to detect significant differences between the ACT and 
CBT intervention groups (see Table 2). 
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[INSERT TABLE 2 NEAR HERE] 
 
Smout et al. (2010) compared ACT with CBT in methamphetamine users (n=90). A 
BDI-II mean score of 27.8 at baseline indicates reporting of moderate symptoms of 
depression. Within the ACT group a large effect size was reported (d=1.02) in the 
reduction of depression 12 weeks post intervention. There were no significant 
differences reported between groups in the change in depression from baseline to 
follow-up; the sample size was reported as not being sufficient to detect between 
group differences and effect sizes were not reported. Furthermore, Hayes et al. 
(2004) compared ACT with Intensive 12-step Facilitation with methadone maintained 
polysubstance users (n=124). Mean depression score measured by the BDI for the 
ACT group at baseline was 18.76, indicating the symptoms reported were in the mild 
range pre-intervention. Comparison between these groups was not made as the 
study was underpowered to detect differences and between group effect sizes were 
not reported. The authors report a small effect size (d=.17) within the ACT 
intervention group in reducing depression post intervention (see Table 2.).  
Wetherell et al. (2011) compared group ACT with group CBT in a chronic pain 
sample (n=114). An average BDI-II score at baseline of 18 indicated mild depressive 
symptom reporting. A large effect size (d=.79) in the reduction of depression within 
the ACT group post intervention was reported and a small effect size (d= .30) 
maintained at 6-month follow up. There were however no between group differences 
reported comparing ACT intervention to CBT intervention in the reduction in 
depression post intervention or at 6-month follow-up (p=.26 and p=.92 respectively) 
(see Table 2.). Westin et al. (2011) compared ACT with Tinnitus Retraining Therapy 
(TRT) in a tinnitus sample. The sample did not indicate clinically significant levels of 
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depression at baseline as measured by the HADS. The author reported no effect of 
ACT intervention in the reduction of depression and no significant difference in the 
reduction of depression between ACT and TRT groups (see Table 2). 
RCTs comparing ACT with control 
Bohlmeijer et al. (2011) examined the effectiveness of ACT intervention compared to 
waiting list control in a clinical depression sample (n=93). Mean depression scores at 
baseline as measured by the Centre for Epidemiology Studies Depression Scale 
(CES-D) were 24, indicating the sample were reporting moderate to severe 
depressive symptoms at baseline. A medium effect size (d=.60) between the groups 
in the reduction of depressive symptoms was reported following intervention (see 
Table 2.). Petersen and Zettle (2009) examined the effectiveness of ACT compared 
to TAU in a sample with depression and comorbid alcohol use disorder (n=24). 
Moderate levels of depressive symptoms were reported at baseline (mean BDI-II 
score= 22.5) and a large effect size (d=1.27) in the reduction of depression post ACT 
intervention compared to TAU (see table 2).  
Gratz and Gunderson (2006) investigated the effectiveness of ACT compared to 
TAU for deliberate self harm in Borderline Personality Disorder (n=22). A mean score 
on the Depression Anxiety Stress Scales of 19 indicated mild levels of depression 
baseline. The authors report a large between group effect size (d=1.3) in the 
reduction of depression in favour of ACT (see Table 2). Wicksell et al. (2008) 
examined a sample with chronic pain and whiplash associated disorders (n=21). 
Comparing ACT with W/L control subjects reported mild symptoms of depression at 
baseline, as measured by the HADS. A large between group effect size in the 
reduction of depression was reported (d=2.44) four months post ACT intervention, 
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when compared to wait list control (see Table 2.) Gaudiano and Herbert (2006) 
examined the effectiveness of ACT intervention compared to TAU in a psychosis 
sample (n=40). The authors report a marginally significant improvement (p=0.06, 
d=.36) on the BPRS affect subscale post intervention with those in the ACT condition 
compared to control (see Table 2). White et al. (2011) examined a psychosis sample 
comparing ACT with TAU (n=27). Mild symptoms of depression at baseline were 
indicated as measured by the HADS. A medium effect size (d=.43) in the reduction 
of depression post intervention comparing ACT with TAU was reported (see Table 
2).  
 
Effects on anxiety following intervention 
RCTs comparing ACT with another active treatment 
Twohig et al. (2010) reported mean anxiety in both groups (ACT and PRT) and at 
baseline was classified to be in the severe range in their OCD sample (n= 79) as 
measured by the Y-BOCS. Participants in both conditions showed improvements in 
anxiety symptoms but within the ACT condition produced a large and significant 
within group difference in rate of improvement (end point outcome effect size d=.84). 
No between group effect size was reported (See Table 3). Forman et al. (2007) 
examined a sample reporting depression and/or anxiety symptoms (n=101) 
comparing ACT with CBT. The mean anxiety score at baseline, as measured by the 
BAI, indicated the sample were presenting with mild symptoms. No significant 
differences were reported between the groups (p=.860, d=.00) and a small effect 
size (d=0.31) was reported in the reduction in anxiety within the ACT intervention 
group (see Table 3).  
[INSERT TABLE 3 NEAR HERE] 
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Wetherell et al. (2011) compared group ACT with group CBT for chronic pain 
(n=114). No significant differences between the groups are reported post intervention 
(p=.90) and at 6-month follow up (p=.73) effect sizes were not reported.  However, 
the authors reported a large effect size (d=.99) post ACT intervention and small 
effect size (d= .05) at 6 months in the reduction of anxiety within the ACT group as 
measured by the Pain Anxiety Symptom Scale. Westin et al. (2011) compared ACT 
with TRT in a tinnitus sample (n=63). Baseline levels of anxiety were indicated as not 
meeting clinical caseness (Mean HADS score= 4). No significant differences are 
indicated in the reduction of anxiety between groups, effect sizes were not reported. 
A large effect size (d=.80) in the reduction in anxiety within the ACT intervention 
group is indicated post intervention (see Table 3.).  
RCTs comparing ACT with control on anxiety outcomes 
Bohlmeijer et al. (2011) examined the effectiveness of ACT versus W/L control 
(n=93) in a clinical depression sample. A HADS-A score at baseline of 9.56 indicated 
the sample were reporting symptoms associated with mild levels of anxiety at 
baseline. A medium effect size in the reduction of anxiety symptoms (d=.67) 
following ACT intervention compared to control condition was reported (see Table 
3.). Gratz and Gunderson’s (2006) examination of the effectiveness of ACT 
compared to TAU for deliberate self harm in Borderline Personality Disorder (n=22), 
reported a mean score on the Depression Anxiety Stress Scales of 19 indicating 
symptoms associated with mild anxiety at baseline. The authors report a large effect 
size (d=2.5) for the reduction of anxiety post ACT intervention compared to TAU. 
Within group effect sizes were are not reported (see Table 3.)  
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White et al. (2011) examined ACT compared to TAU in a psychosis sample (n=27). 
An effect size of (d=.03) is reported for anxiety reduction post intervention in the ACT 
group compared to TAU, indicating no significant effect on anxiety reduction. 
However, the mean baseline score on the HADS indicated the sample was not 
reporting clinically important levels of anxiety. Wicksell et al. (2008) examined a 
sample with chronic pain and whiplash associated disorders (n=21) presenting with 
mild levels of anxiety at baseline, as measured by the HADS. The authors reported a 
large effect size (d=.87) for ACT compared to control in the reduction of anxiety in 
whiplash disorder at four months post intervention (see Table 3).  
The effect of ACT on psychological flexibility 
A summary of the effect of ACT intervention on psychological flexibility reported by 
the RCTs can be found in Table 4. When considering trials comparing ACT with 
other active treatments, Wetherell et al. (2011) reported a large effect size (d=1.64) 
in the increase of acceptance of chronic pain post ACT intervention, as measured by 
the Chronic Pain Acceptance Questionnaire- Revised, and medium effect size 
(d=.44) maintained at 6 month follow up within the ACT group. They reported no 
significant difference in improvement in acceptance between ACT and CBT 
intervention groups (p=.58) although, no effect sizes were reported. Lappalainen et 
al. (2007) compared ACT and CBT in an out-patient primary care population, using 
the AAQ-8, the authors reported that ACT intervention produced significant pre to 
post improvements in acceptance (p=.007, d=.83) whilst CBT did not.   
[INSERT TABLE 4 NEAR HERE] 
 
27 
 
Westin et al. (2011) reported a large effect size (d=1.6) within the ACT group in the 
improvement of acceptance of tinnitus post intervention, the authors do not report 
between TRT and ACT groups comparisons for acceptance. Forman et al. (2007) 
compared ACT with CT in a sample with depression and anxiety. As measured by 
the AAQ-9 item, the authors report no significant difference between ACT and CT 
group in improvement in psychological flexibility (p=.890, d=.00). A medium effect 
size (d=0.42) within the ACT group in relation to an increase in psychological 
flexibility post ACT intervention is reported. Twohig et al. (2010) examined and OCD 
sample using the AAQ-16 and reported a medium effect size (d=.59) in improvement 
of psychological flexibility immediately post-intervention in ACT compared to PRT; 
compared to a small between-group effect size (d= .22) at 3-month follow up. Within 
group effect sizes pre to post intervention were d=.47 and d=.64 for PRT and ACT 
respectively. 
When considering trials comparing ACT with control, Petersen and Zettle (2009) 
examined a sample with depression and alcohol use disorder and reported that 
statistically significant reductions in AAQ-9 scores were noted only for those 
participants who received ACT (p=.01, d=1.32).  Gratz and Gunderson (2006) also 
used the AAQ-9 to compare ACT with TAU in deliberate self harm in BPD, they 
reported a large effect size in the improvement in psychological flexibility (d=4.2) in 
the ACT intervention compared to TAU. Within group effect size were d= 4.3 and 
d=.37 for ACT and TAU respectively. Bohlmeijer et al. (2011) compared ACT with 
W/L control in a depression sample and reported a medium between group effect 
size (d=.59) in the improvement in psychological flexibility in favour of the ACT 
condition, as measured by the AAQ-II 10-item post intervention. Further, White et al. 
(2011) reported a small effect size (d=.13) in the improvement in psychological 
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flexibility post ACT intervention in a Psychosis sample between ACT and TAU also 
measured by the AAQ-II 10 item version. Within group effect sizes were not 
reported. Finally, Wicksell et al. (2008) reported large between group effect sizes in 
the reduction of avoidance (d=2.5) and fusion (d=1.43) associated with distress in 
whiplash disorder at 4-months follow-up in favour of the ACT condition as measured 
by the Psychological Inflexibility in Pain Scale. Effect size for reduction of avoidance 
and fusion within the ACT group were d=2.5 and d=1.7 respectively.  
 
Synthesis of effect size of studies with clinically significant symptoms at baseline 
The median pre-post effect size (Cohen’s d) based on the between group studies 
comparing ACT with an active treatment (N=3 and N=2 respectively) was d=0.53 
(0.00-6.56) for depression and d=0.43 (0.00-0.85) for anxiety. The median pre-post 
effect size based on the between group studies comparing ACT with control was 
d=0.94 (0.60-2.50) for depression and d= 0.77 (0.03-1.34) for anxiety (N=6 and N=4 
respectively). The median pre-post effect size based on the within the ACT group 
was d=1.02 (0.17-1.52) for depression and d=0.84 (0.80-2.50) for anxiety (N=7 and 
N=5 respectively). (See Table 5. for a summary of effect sizes across the RCTs). It is 
apparent that between subject effects sizes in the reduction of anxiety and 
depression are larger when comparing ACT with a no treatment control condition as 
opposed to an active treatment. Whilst the effect sizes in the reduction of anxiety and 
depression are largest within the ACT interventions.  It is also interesting to note that 
the effect sizes for depression are consistently higher than for anxiety irrespective of 
whether this was for between group or within group comparing ACT with active 
treatment or ACT with control. 
[INSERT TABLE 5 NEAR HERE] 
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Discussion 
This systematic review aimed to examine the effects of ACT on depression and 
anxiety in clinical populations. When considering the effectiveness of ACT in 
reducing depression compared to other active treatments, ACT was compared with 
CBT across four studies (Forman et al. 2007; Lappalainen et al. 2007; Smout et al. 
2010; Wetherell et al. 2011). Lappalainen et al. (2007) was the only RCT to report 
between group differences in the reduction of depressive symptoms in favour of ACT 
over CBT. No significant differences between ACT and CBT intervention in 
depression symptom reduction were reported within a depression/anxiety sample 
(Forman et al. 2007), methamphetamine using sample (Smout et al. 2010) or a 
chronic pain sample (Wetherell et al. 2011). However, medium to large effect sizes 
within the ACT intervention groups in the reduction of depression were reported 
across the four studies.  
When considering the efficacy of ACT in reducing depression compared to control, 
medium to large effect sizes in depression reduction and improvement in 
psychological flexibility following ACT intervention were reported across five studies 
(Bohlmeijer  et al. 2011; Petersen & Zettle, 2009; Gratz & Gunderson, 2006; White et 
al. 2011; Wicksell et al. 2008).  These studies recruited participants with depression, 
depression comorbid with alcohol use, self-harm in BPD, psychosis and chronic pain 
respectively. Gaudiano and Herbert (2006) reported a marginally significant 
reduction in depression following an ACT intervention. Symptoms were however 
measured by the BPRS-affect subscale rather than a specific measure of 
depression. 
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Two studies compared the efficacy of ACT in reducing anxiety symptoms with CBT: 
Wetherell et al. (2011) examined a chronic pain sample and Forman et al. (2007) 
examined a depression/anxiety sample. Both studies reported no significant 
difference between groups in the reduction of anxiety following intervention, and no 
between-group effect sizes were reported. Medium effect sizes in the reduction of 
anxiety and impairment in psychological flexibility within ACT were reported. No 
significant differences in the reduction of anxiety were reported comparing ACT with 
TRT in the tinnitus sample examined by Westin et al. (2011). However this study 
recruited individuals with minimal levels of depression and anxiety at baseline.  A 
large within ACT group effect in the reduction of anxiety following intervention is 
however reported. Twohig et al. (2010) report a significant difference in favour of 
ACT compared to PRT in the reduction of anxiety and improvement in psychological 
flexibility in an OCD sample. Whilst the above studies indicate the effectiveness of 
ACT in reducing anxiety within various clinical samples, the efficacy of ACT 
compared to other active treatment is less clear. 
Four studies reported on the effectiveness of ACT in reducing anxiety compared to 
control (Bohlmeijer et al. 2011; Gratz & Gunderson, 2006; Wicksell et al. 2008; White 
et al. 2011). Bohlmeijer et al. (2011), Gratz and Gunderson (2006) and Wicksell et al. 
(2008) reported medium to large between group effect sizes in the reduction of 
anxiety symptoms following ACT intervention in depression and chronic pain and self 
harming samples that reported were assessed as having mild anxiety at baseline. 
White et al. (2011) reported no significant effect in the reduction of anxiety but this 
may have been due to the fact that the sample of individuals with psychosis were 
only mildly anxious at baseline. Generally however, the research evidence suggests 
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that ACT may help reduce anxiety compared to control across clinical populations 
presenting with mild anxiety at baseline.  
Methodological Quality and Effect Sizes 
The methodological quality of the 13 studies was variable, 54% of the studies failed 
to report the use of blinding to group assignment. Those with high quality scores 
reported the process of randomisation and allocation in the methodology and the 
process of blinding to group assignment was made clear. According to Hemple et al. 
(2007), effect sizes can be influenced by other variables independent from trial 
quality. For example, it is possible that poor reporting in publication does not 
necessarily mean the actual delivery of poor study quality. Furthermore, due to the 
heterogeneous nature of the clinical populations included in the studies, the outcome 
measures used to examine depression and anxiety symptoms within the samples 
were varied. Both objective and subjective measures were used and it is possible 
that the sensitivity of the outcome measures in identifying and measuring affective 
symptoms was variable also. There was also a variation across the studies in 
baseline clinical severity which may have affected the effect sizes following 
intervention. For example, in a sample presenting with sub-clinical or mild symptoms 
at baseline it may be difficult to identify symptom change. The reported effect sizes 
examined in this review have highlighted that the relationship between effect size 
reporting and methodological quality is complex and further research is required to 
further examine the efficacy of ACT on depression and anxiety within clinical 
populations. In particular more research is required that recruits participants with 
moderate to severe levels of depression and anxiety. 
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Limitations 
A number of limitations to this review should be noted. Firstly, the results are limited 
to the systematic review methodology employed and are therefore dependant on the 
study selection criteria and the quality of the studies included. Secondly, many of the 
studies had small sample sizes or large attrition meaning they were under powered 
to detect between group differences. Thirdly, there were also a lack of prospective 
and longitudinal studies therefore the convenience sampling employed by many of 
the studies leads to the inclusion of mostly treatment seeking participants. Fourthly, 
difficulties relating to publication bias mean that studies that did not find an effect of 
ACT on depression and/or anxiety may not have been published and therefore not 
included in this review.  Finally, due to the heterogeneous nature of the samples 
included in the systematic review, a variety of psychometric measures were used 
across the studies to measure anxiety and depression. The quality and sensitivity of 
the measures used to examine depression and anxiety were therefore not 
consistent. These methodological restrictions limit the generalisability of the findings 
reported in the systematic review. Greater consistency in the measures used would 
facilitate easier comparison between studies in the future. 
 
Implications for research  
Despite a growing body of research indicating the effectiveness of ACT intervention 
on reducing depression and anxiety across clinical disorders, longer duration of 
follow up is required to examine if these effects (including the development of 
increased psychological flexibility) are maintained over time. More research is also 
needed to explore the effectiveness of ACT on depression and anxiety in individuals 
experiencing moderate to severe levels of depression and anxiety at baseline. Every 
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effort should be made to maintain high retention rates in studies and reasons for 
withdrawal should be ascertained so that factors affecting treatment adherence as 
well as robust comparisons between other therapies such as CBT can be further 
explored. More emphasis needs to be placed on investigating the association 
between changes in psychological flexibility (and related measures like mindfulness) 
with changes in outcome measures.  
Implications for clinical practice 
This review has revealed evidence indicating the effectiveness of ACT intervention in 
reducing depression and anxiety within clinical populations. The studies reviewed 
report robust within-group effect sizes following intervention ranging from eight to 32 
sessions in group based and one-to-one formats. This highlights the potential for the 
successful application of ACT consistent therapies as part of the delivery of routine 
psychological care. The application of ACT within these setting has the potential to 
support the delivery of stepped care approaches and therapy access targets such as 
those associated with Delivering for mental health (Scottish Executive, 2006).  Any 
facilitation of ACT intervention within these settings should be led by mental health 
professionals trained in ACT and these professionals would be required to take a 
lead role in the training and supervision of others involved in supporting the delivery 
of ACT in routine clinical settings. 
 
Conclusions 
This review has examined the effectiveness of ACT intervention delivered directly by 
therapists in reducing symptoms of depression and anxiety. Ten of the 13 studies 
reviewed have examined the effectiveness of ACT in clinical samples with mental 
health disorders; chronic pain and tinnitus samples were also examined. The 
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systematic review data indicate that ACT intervention, delivered in an individual and 
group setting, is effective in reducing symptoms associated with depression and 
anxiety relative to treatment as usual or control. ACT is also effective in improving 
psychological flexibility in the context of reducing experiential avoidance and 
cognitive fusion associated with experiences of depression and anxiety across a 
range of disorders. ACT is therefore effective in reducing anxiety and depression 
through supporting a reduction in experiential avoidance and increase in 
psychological flexibility, even when the intervention is not targeting anxiety or 
depression directly. However, it is possible that non-specific factors may have been 
responsible for within group changes. The review of between group effect sizes 
comparing ACT with other therapies indicates that the efficacy of ACT in comparison 
to other active treatments requires further research. 
 
Effect sizes were consistently larger for depression outcomes compared to anxiety in 
both within and between group comparisons. This might indicate that symptoms 
associated with depression are more synonymous with psychological inflexibility than 
anxiety symptoms. Furthermore, the distress tolerance approach that ACT 
advocates may result in participants continuing to score high on anxiety measures; 
however, they are more able to function with the presence of these symptoms, 
engaging in committed action, despite anxiety experiences.  It is interesting to note 
that reductions in depression were associated with improvements in psychological 
flexibility in two of the studies directly targeting depressive symptoms (Bohlmeijer et 
al. 2011; Forman et al. 2007) and in the study of a psychosis sample by White et al. 
(2011). However in the absence of the other studies assessing correlations between 
changes in depression/anxiety with changes in psychological flexibility, it is difficult to 
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ascertain the extent to which changes in these measures were related. Furthermore, 
due to the processes explored by ACT, intervention is not required to be targeted in 
a way that is disorder specific. Instead, dysfunctional processes affecting mood and 
anxiety that occur across disorders and affect well-being can be targeted through an 
ACT consistent approach.  
 
In summary, ACT delivered in group and individual settings is indicated to be 
effective for those experiencing symptoms of depression and anxiety in the mild 
range as well as those presenting with more moderate to severe distress. However, 
this review has highlighted that further research is required examining the 
effectiveness of ACT compared to other active treatments before it can be indicated 
as a first line treatment or superior to other active treatments.  
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Figure 1. Flow diagram of selection of papers for inclusion in the systemic 
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Table 1. Summary of included studies 
Study Clinical Population Total N Mean Age Type of ACT 
Intervention 
Comparison 
Condition 
N intervention 
sessions 
Depression 
Measure 
Anxiety 
Measure 
ACT 
Measure 
Quality 
Rating 
Score * 
White et al 
(2011) 
Psychosis N=27 34 ACT TAU 10 sessions HADS HADS AAQ 
10item 
50 
Twohig et al 
(2010) 
Obsessive Compulsive 
Disorder 
N=79 37  ACT PRT 8 sessions BDI-II Y-BOCS AAQ 
16 item 
48 
Westin et al 
(2011) 
Tinnitus N=63 50 ACT TRT or W/L 10sessions HADS HADS TAQ 48 
Wetherell et al 
(2011) 
Chronic Pain N=114 Not 
reported 
Group ACT Group CBT 8 sessions BDI-II PASS CPAQ-R 46 
Gaudiano& 
Herbert (2006) 
Psychosis N=40 40 ACT TAU Mean = 3 BPRS- affect 
subscale 
- - 45 
Wicksell et al 
(2008) 
Chronic Pain and 
Whiplash- Associated 
Disorders 
N=21 52 ACT W/L Control 10 sessions HADS HADS PIPS 42 
Smout et al 
(2010) 
Methamphetamine Use N=90 31 ACT CBT 12 sessions BDI-II -  41 
Petersen 
&Zettle (2009) 
Comorbid Depression 
and Alcohol Use 
Disorder 
N=24 37 ACT TAU Mean = 6 
sessions 
BDI-II 
HRS 
- AAQ 
9 item 
40 
Forman et al 
(2007) 
Depression and 
Anxiety 
N=101 28 ACT CT Mean = 15 
sessions 
BDI-II BAI AAQ 
9 item 
39 
Bohlmeijer et al 
(2011) 
Depression N=93 49 Group ACT W/L Control 8 sessions CES-D HADS- 
Anxiety 
Subscale 
AAQ=II 
10 item 
38 
Gratz& 
Gunderson 
(2006) 
Deliberate Self Harm in 
Borderline Personality 
Disorder 
N=22 33 Group ACT TAU 14 sessions DASS 
21 item 
DASS 
21 item 
AAQ 
9 item 
38 
Hayes et al 
(2004) 
Polysubstance Users 
on Methadone 
Maintenance 
N=124 42 ACT+ 
Methadone 
ITSF+ Methadone 
or Methadone  
32 (individual) 
16 (group) 
BDI - - 36 
Lappalainen et 
al (2007) 
Adult Mental Health N=28 41 ACT CBT Mean= 9 BDI - AAQ 
8 item 
32 
Note 
AAQ= Acceptance and Action Questionnaire; BAI= Beck Anxiety Inventory; BPRS= Brief Psychiatric Rating Scale; DASS= Depression Anxiety Stress Scales; BDI-II= Beck Depression 
Inventory- 2nd Edition; CBT= Cognitive Behavioural Therapy; CES-D, Centre for Epidemiological Studies Depression Scale; CPAQ-R- Chronic Pain Acceptance Questionnaire-Revised; CT= 
Cognitive Therapy;  HADS= Hospital Anxiety and Depression Scale;  HRS, Hamilton Rating Scale; PASS= Pain Anxiety Symptoms Scale-Short Form; PIPS= Psychological Inflexibility in Pain 
Scale; PRT= Progressive Relaxation Training; TAU= Treatment As Usual; TAQ= Tinnitus Acceptance Questionnaire; TRT= Tinnitus Retraining Therapy; VLQ= Valued Living Questionnaire; 
W/L= Waiting List;  Y-BOCS= Yale Brown Obsessive Compulsive Scale. 
 * The quality rating scores (Median= 41, IQR= 9) were derived from the rating of each study against a checklist, which examined the adequate reporting of study design, 
methodology, intervention and analysis. The higher the score, the greater the methodology quality of the RCT. 
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Table 2. Reduction in depression as a result of ACT intervention 
Study Clinical Population Intervention Measure Mean score 
and 
classification 
at baseline 
Follow Up Period Statistical 
Reporting 
Effect Size Quality Rating 
Score 
Twohig et al 
(2010) 
Obsessive 
Compulsive 
Disorder 
ACT vs PRT  BDI-II “at least mildly 
depressed” 
BDI-II cut off 
+13  
70% of total 
sample 
3 Months t( 62.82)= -2.06, 
 p= .044,  
d=.63 (Medium)  
ACT vs PRT 
d= 1.52 (Large) 
Within ACT 
 
48 
Bohlmeijer et al 
(2011) 
Depression Group ACT vs W/L 
Control 
CES-D +16 indicates 
clinical 
depression 
ACT group 
baseline mean 
= 24  
Post intervention F (9.19),p= .003, 
 
d= .60 (Medium) 
ACT vs Control 
38 
Petersen &Zettle 
(2009) 
Comorbid 
Depression and 
Alcohol Use 
Disorder 
ACT vs TAU BDI-II 
 
 
+ 13 indicates 
caseness 
 
ACT mean 
score at 
baseline=22.5 
(Moderate) 
Post Intervention Pre M= 22.5 
(12.3) 
Post M= 8.0 
(10.4) 
 
d= 1.27 (Large) 
ACT vs TAU 
40 
Wicksell et al 
(2008) 
Chronic Pain and 
Whiplash- 
Associated 
Disorders 
ACT vs W/L Control HADS + 8 indicates 
caseness 
ACT group 
mean at 
baseline = 8.1 
(Mild) 
4 Months F (22.8), p= 
<.001,  
 
d= 2.44 (Large) 
ACT vs W/L 
Control 
42 
Forman et al 
(2007) 
Depression and 
Anxiety 
ACT vs CT BDI-II + 13 indicates 
caseness 
At baseline 
ACT m=19.23 
CT m=18.92 
(mild) 
Post Intervention 
Within ACT 
 
 
 
Between groups 
Pre M= 19.23 
(10.15) 
Post M= 12.84 
(9.33) 
 
F (0.04), p= .837 
d= 0.65 
(Medium) 
 
 
 
No Significant 
Difference 
 
 
 
39 
46 
 
Wetherell et al 
(2011) 
Chronic Pain Group ACT vs Group 
CBT 
BDI-II + 13 indicates 
caseness 
At baseline 
ACT m=18.7 
CBT m=15.5 
(Mild) 
Within ACT 
Post Intervention 
 
6 Months 
 
Between groups 
Post Intervention 
 
6 Months 
 
 
t= -3.73, 
p=.0005 
 
t= 1.13, p= .26 
 
 
F (1.31), p= .26 
 
F (0.01), p= .92 
 
d= .79 (Large) 
 
d= .30  (Small) 
 
 
Non Significant 
 
Non Significant 
46 
Smout et al 
(2010) 
Methamphetamine 
Use 
ACT vs CBT 
(Sample Size not 
sufficiently Powered to 
detect  between group 
differences) 
BDI-II + 13 indicates 
caseness 
ACT mean at 
baseline =27.8 
CBT mean at 
baseline =25.7 
(Moderate) 
Post Intervention Within ACT 
Pre M= 27.8 
(10.3) 
Post M= 15.4 
(13.6) 
 
d= 1.02 
(Large) 
41 
Gratz& 
Gunderson 
(2006) 
Deliberate Self 
Harm in Borderline 
Personality 
Disorder 
Group ACT vs TAU DASS 
21 item 
+ 12 indicates 
caseness 
Mean ACT 
group at 
baseline= 
19.17 
(Mild) 
Post Intervention Within ACT 
F (20.44), 
p=<.01 
 
ACT vs TAU 
F(1,19), p=<0.05  
 
d= 4 
(Large) 
 
d= 1.3       
(Large) 
38 
Lappalainen et al 
(2007) 
Adult Mental 
Health 
ACT vs CBT 
Study under powered 
to detect between 
group differences 
BDI + 10 indicates 
caseness 
Mean ACT 
group at 
baseline=14.1 
Mean CBT 
group at 
baseline=18.49 
(Mild) 
Post Intervention 
 
Within ACT  
Z= -2.76, p <.01 
 
Between ACT vs 
CBT 
d= 0.83  
(Large) 
 
d= .53 
(Medium) 
32 
Hayes et al 
(2004) 
Polysubstance 
Users on 
Methadone 
Maintenance 
ACT+Methadonevs 
ITSF+ Methadone vs 
Methadone 
Attrition meant study 
was not powered to 
detect between subject 
differences 
BDI + 10 indicates 
caseness 
ACT group 
mean at 
baseline= 
18.76 
(Mild) 
Post Intervention Within ACT 
Pre M= 18.76 
(9.16) 
Post M= 17.04 
(10.94) 
 
d= 0.17 
(Small) 
36 
Gaudiano& 
Herbert (2006) 
Psychosis ACT vs TAU BPRS- affect 
subscale 
Mean score at 
baseline =25 
Post Intervention F=6.45 
p=0.06 
d=0.36 
 
 
 
45 
47 
 
White et al 
(2011) 
Psychosis ACT vs TAU HADS- 
depression 
subscale 
+ 8 indicates 
caseness 
ACT group 
mean at 
baseline = 8.62 
(Mild) 
Post Intervention 
Between groups 
t = -2.09,  
p= .051  
 
d= 0.43 
(Medium) 
50 
Westin et al 
(2011) 
Tinnitus ACT vs TRT or W/L HADS- 
depression 
subscale 
+ 8 indicates 
caseness 
ACT group 
mean at 
baseline = 6.24 
(Non clinical) 
Post Intervention 
 
Within ACT 
 
 
ACT vs W/L 
 
 
 
ACT vs TRT 
 
 
No effect 
reported 
 
No significant 
difference 
reported 
 
No significant 
difference 
reported 
 
 
No effect 
 
 
No significant 
difference 
 
 
No significant 
difference  
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48 
 
 
Table 3. Reduction in anxiety as a result of ACT intervention 
Study Clinical 
Population 
Intervention Measure Mean score 
and 
classification 
at baseline 
Follow Up Period Statistical 
Reporting 
Effect Size Quality Rating 
Score 
Twohig et al 
(2010) 
Obsessive 
Compulsive 
Disorder 
ACT vs PRT  Y-BOCS Means at 
baseline 
ACT= 22.22  
PRT= 25.40  
(Severe) 
3 Months t( 80.64)= 2.27, 
 p= .026,  
d=.84 (Large) 
Within ACT 
48 
Bohlmeijer et al 
(2011) 
Depression Group ACT vs W/L 
Control 
HADS-
Anxiety 
Subscale 
Caseness 
defined by 
score of + 8 
ACT group 
mean at 
baseline = 
9.65 (mild) 
Post intervention F (7.94), p= .006, 
 
d= .67 (Medium) 
ACT vs Control 
38 
Wicksell et al 
(2008) 
Chronic Pain 
and Whiplash- 
Associated 
Disorders 
ACT vs W/L Control HADS + 8 indicates 
caseness 
ACT group 
mean at 
baseline = 8.3 
(mild) 
4 Months F (2.9), p= .111,  
 
d= .87 (Large) 42 
Forman et al 
(2007) 
Depression and 
Anxiety 
ACT vs CT BAI + 8 indicates 
caseness 
At baseline 
ACT m=13.42 
CT m=13.08 
(Mild) 
Post Intervention 
Within ACT 
 
 
 
Between groups 
Pre M= 13.42 
(10.20) 
Post M= 10.32 
(9.57) 
 
F (0.03), p= .860 
d= 0.313 
(Small) 
 
 
 
d=.00 
39 
Wetherell et al 
(2011) 
Chronic Pain Group ACT vs Group 
CBT 
PASS ACT mean at 
baseline= 45.5 
CBT mean at 
baseline= 41.7 
 
Within ACT 
Post Intervention 
 
 
6 Months 
 
Between groups 
Post Intervention 
 
 
6 Months 
 
t= (-3.74), p= 
.0004 
 
 
t= (0.19), p= .85 
 
 
F= (0.02), p= .90 
 
F= (0.12), p= .73 
 
d= .99  (Large)  
 
 
d= .05  (Small) 
 
 
Non Significant 
 
 
Non Significant 
 
46 
49 
 
Gratz& 
Gunderson 
(2006) 
Deliberate Self 
Harm in 
Borderline 
Personality 
Disorder 
Group ACT vs TAU DASS 
21 item 
+ 5 indicates 
caseness 
Mean ACT 
group at 
baseline= 14.5 
Post Intervention Within ACT 
F (17.62), p=<.01 
 
ACT vs TAU 
F(1,19), p=<.01 
d= 2.5 (Large) 
 
d= 1.34 (Large) 
38 
White et al 
(2011) 
Psychosis ACT vs TAU HADS- 
anxiety 
subscale 
+ 8 indicates 
caseness 
ACT group 
mean at 
baseline =8.57 
(Mild) 
Post Intervention 
Between groups 
t = 0.12, p= 0.904 
 
d= 0.03 
(No significant 
effect) 
50 
Westin et al 
(2011) 
Tinnitus ACT vs TRT or W/L HADS-
anxiety 
subscale 
+ 8 indicates 
caseness 
ACT group 
mean at 
baseline = 
4.05 
(Non clinical) 
Post Intervention 
Within ACT  
 
 
ACT vs TRT 
F(1,42)=4.40,  
p=0.042 
 
 
No significant 
difference 
reported 
d= .80   
(Large) 
 
 
No significant 
difference 
48 
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Table 4. Improvement in psychological flexibility as a result of ACT intervention 
Study Clinical 
Population 
Intervention Measure Follow Up Period Statistical Reporting Effect Size Quality Rating 
Score 
Twohig et al (2010) Obsessive 
Compulsive 
Disorder 
ACT vs PRT  AAQ 16 item Post intervention 
 
 
 
 
 
3 Months 
t( 70.22)= -2.50, 
 p= .015,  
 
 
 
 
t( 67.89)= -.92, 
 p= .36,  
d=.59 (Medium) 
ACT vs PRT 
 
D= 1.06 (Large) 
Within ACT 
 
d=.22 (Small) 
ACT vs PRT 
 
d= .86 (Large) 
Within ACT 
 
48 
Bohlmeijer et al 
(2011) 
Depression Group ACT vs W/L 
Control 
AAQ=II 
10 item 
Post intervention F (10.47), p= .002, 
 
d= .59 (Medium) 38 
Petersen &Zettle 
(2009) 
Comorbid 
Depression and 
Alcohol Use 
Disorder 
ACT vs TAU AAQ 
9 item 
Post intervention t(11)= 3.19, p= 
<.01,  
 
d=1.32 (Large) 
Within ACT 
40 
Wicksell et al 
(2008) 
Chronic Pain and 
Whiplash- 
Associated 
Disorders 
ACT vs W/L Control PIPS-
Avoidance 
 
 
PIPS- Fusion 
4 Months F (24.6), p= <.001 
 
 
F (8.2), p= .011,  
 
d= 2.5 
(Large) 
 
d= 1.43 
(Large) 
42 
Forman et al 
(2007) 
Depression and 
Anxiety 
ACT vs CT AAQ 
9 item 
Post Intervention 
Within ACT 
 
 
Between 
Pre M= 52.64 (6.54) 
Post M= 49.68 
(7.49) 
 
F (0.02), p= .890 
d= 0.42 
(Medium) 
 
 
No Significant 
Difference 
39 
Wetherell et al 
(2011) 
Chronic Pain Group ACT vs Group 
CBT 
CPAQ-R Within ACT 
Post Intervention 
 
 
6 Months 
 
Between groups 
Post Intervention 
 
 
 
t= 6.17, p= <.0001 
 
 
t= -1.68, p=.10 
 
F (0.30), p=.58 
 
 
 
 
d= 1.64  Large 
 
 
d= .44 Medium 
 
Non Significant 
 
 
 
46 
51 
 
6 Months F (0.01), p= .97 Non Significant 
Gratz& Gunderson 
(2006) 
Deliberate Self 
Harm in 
Borderline 
Personality 
Disorder 
Group ACT vs TAU AAQ 
9 item 
Post Intervention Within ACT 
F (50.34), p <.01 
 
ACT vs TAU 
F(1.19), p=<.01  
d= 4.2 (Large) 
 
d= 3.7 (Large) 
38 
Lappalainen et al 
(2007) 
Adult Mental 
Health 
ACT vs CBT 
Study under powered to 
detect between group 
differences 
AAQ 
8 item 
Post Intervention 
 
Within ACT 
Z= -2.71, p= .007 
 
d= 0.83 
(Large) 
32 
White et al (2011) Psychosis ACT vs TAU AAQ-II 
 
Post Intervention t = 0.60, p= 0.557 
 
d=  0.13 
(Small) 
 
50 
Westin et al (2011) Tinnitus ACT vs TRT or W/L TAQ Post Intervention 
Within ACT  
t(21)= -3.62,  
p= .002 
d= 1.6 
(Large) 
48 
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Table 5. Synthesis of Effect Sizes 
Effect Size Category Study Cohen’s d 
Depression     Anxiety 
Between group effect size of ACT vs 
Treatment 
Twohig et al. (2010) 
Forman et al. (2007) 
Lappalainen et al. (2007) 
Median 
.63  .85 
.0                     .0 
.53                   - 
.53                   .425 
Between group effect size of ACT vs 
Control 
Bohlmeijer et al. (2011) 
Petersen & Zettle (2009) 
Wicksell et al. (2011) 
Gratz& Gunderson (2006) 
Gaudiano& Herbert (2006) 
White et al. (2011) 
Median 
.6                   .67 
1.27                 - 
2.44                .87 
1.3                  1.34 
.36                   - 
.43                  .03 
.94                  .77 
Within group effect size of ACT 
group 
Twohig et al. (2010) 
Forman et al. (2007) 
Wetherell et al. (2011) 
Smout et al. (2010) 
Gratz&Gunderson (2006) 
Lappalainen et al. (2007) 
Hayes et al. (2004) 
Westin et al. (2011) 
Median 
1.52                .84 
.65                  .32 
.79                  .99 
1.02                - 
4.0                  2.5 
.83                  - 
.17                  - 
-                     .80 
1.02                .84 
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Plain Language Summary 
 
Aims of the study: The study aimed to find out if a defusion intervention was effective 
at reducing distress associated with negative self-cognitions. This study also 
investigated how depression experienced by individuals with psychosis was related to 
internal shame, psychological flexibility and emotion regulation abilities. 
What the study involved: Sixteen people took part in the study who had experienced 
psychosis and were considered to have difficulties with depression by NHS staff 
involved in their care. Participants first completed questionnaires about their 
experiences before being randomly split into two groups. One group took part in a 
defusion intervention focussed on coping with difficult thoughts. The second group took 
part in a control task.  
Results: The results from the questionnaires showed that levels of depression were 
associated with internal shame, psychological inflexibility and difficulties regulating 
emotion.  At the end of the study, the people in the intervention group reported lower 
distress about a negative self thought than the people in the control group.   
Conclusions: Depression in psychosis was associated with internal shame, 
psychological inflexibility, and problems coping with difficult thoughts and emotions. The 
use of a brief defusion intervention aimed at reducing distress associated with negative 
self-cognitions merits further exploration. 
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Abstract 
 
Background: Depressive symptoms have been found to accompany and develop 
following psychosis. Depression following psychosis has been associated with negative 
self-cognitions. Acceptance and Commitment Therapy (ACT) posits that avoidance of 
distressing internal experiences can lead to psychological inflexibility and the 
maintenance of distress.  
 
Aims: The study conducted a preliminary investigation into the effectiveness and 
acceptability of a brief ACT-based defusion intervention aimed at increasing 
psychological flexibility and reducing distress associated with negative self-
cognitions.This research also explored the extent to which levels of depression 
experienced by individuals with psychosis are associated with internal shame, 
psychological flexibility and emotion regulation difficulties. 
 
Method: A randomised controlled trial design was used in phase 1 of the study. 
Individuals were randomised to either a brief defusion intervention (N=8) or a control 
condition (N=8).An exploratory correlational design was used in phase 2 of the 
research.Sixteen participants completed questionnaires. 
 
Results: Levels of depression in individuals with psychosis were associated with 
internal shame, psychological inflexibility and difficulties with emotion regulation. A trend 
approaching significance suggested that the change in levels of distress related to a 
negative self cognition in the defusion group was greater than the corresponding 
change for the control group.   
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Conclusions: Individuals randomised to a defusion exercise found the intervention 
acceptable and it appears to offer promise for reducing distress associated with 
negative self cognitions. 
 
Keywords: Psychosis; Depression; Acceptance and Commitment Therapy; 
Psychological Flexibility.  
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Introduction 
Psychological flexibility and the processes of ACT 
Over the past two decades, a number of psychological therapies have emerged that are 
described as third wave cognitive behaviour therapies. Examples of these approaches 
are Mindfulness-Based Cognitive Therapy: MBCT (Segal et al., 2002); Dialectical 
Behaviour Therapy: DBT (Linehan, 1993); Compassion Focused Therapy: CFT (Gilbert, 
2009) and Acceptance and Commitment Therapy: ACT (Hayes et al., 1999).  ACT is 
based on behavioural principles grounded in Functional Contextualism and Relational 
Frame Theory (RFT) (Hayes et al., 2001). ACT conceptualises psychological events, 
including verbal and cognitive processes, as a set of ongoing actions by an individual 
interacting with historically and situationally defined contexts.  
From an ACT perspective, human language and cognition involves the development of 
complex networks of related events.  Blackledge (2003) describes that we respond to 
relations between stimuli rather than just responding to each stimulus separately. This 
has clinical implications as relations between stimuli therefore do not require to be 
learned through direct experience. From a clinical perspective, an ACT consistent 
approach proposes that distress can be reduced by exploring the functional context in 
which symptoms are experienced, as opposed to a direct focus on changing or 
eliminating these symptoms. Hayes et al., (2003) propose that the clinical goal of ACT is 
to undermine the grip of the verbal content of cognition that triggers avoidance 
behaviour and to construct an alternative context, where behaviour is more aligned with 
one’s values and goals. ACT therefore encourages individuals to interact with negative 
thoughts, emotions and physical sensations to reduce experiential avoidance, while 
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simultaneously working towards the pursuit of valued behaviours (Gaudiano et al., 
2006).  
ACT posits that processes that attempt to control, suppress or alter forms of internal 
experiences occur across human experience but can cause behavioural harm and 
distress (Luoma et al., 2007). This concept is described as psychological inflexibility. 
Psychological inflexibility describes active or passive efforts to avoid and/or escape 
private experiences such as affects, thoughts, memories and bodily sensations which 
are experienced as aversive (Hayes et al., 2006). These attempts are often termed 
experiential avoidance. Engaging in positive behaviours rather than attempting to avoid 
difficult internal experiences seeks to generate psychological flexibility.  ACT seeks to 
increase psychological flexibility by targeting several major processes: 
1. Acceptance: The process of acceptance describes one’s willingness to contact 
feared inner experiences; an alternative to experiential avoidance.  
2. Being Present: Refers to the ongoing, non judgemental contact with 
psychological and environmental events as they occur. 
3. Defusion: The process of defusion aims to develop skills allowing the person to 
become aware of their internal experiences without becoming entangled in them.  
4. Self as context: The process of self as context is explored through practice in 
experiencing oneself within the context in which inner experiences occur rather 
than being defined by the content.   
5. Values: ACT places specific emphasis on individuals exploring what it is that they 
value in life.  
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6. Committed action: Individuals are supported to engage in committed action that 
is consistent with them moving towards valued directions.  
These core processes overlap and are interrelated, each supporting psychological 
flexibility and behaviour change (Luoma et al., 2007). 
ACT for Psychosis 
There is emerging evidence for the effectiveness of ACT in the treatment of a range of 
psychological disorders, including distress associated with depression and anxiety 
(Bohlmeijer et al., 2011; Forman et al., 2007), self harm in borderline personality 
disorder (Gratz & Gunderson, 2006), and substance use (Hayes et al., 2004; Smout et 
al., 2010). Bach and Hayes (2002) conducted the first randomised controlled trial of 
ACT for individuals with psychosis. ACT produced lower symptom believability and 
reduced rehospitalisation compared to TAU. A second RCT by Gaudiano and Herbert 
(2006) found that ACT produced greater improvements in symptom related distress, 
affective symptoms and social impairment compared to control. Most recently, White et 
al., (2011) conducted an RCT of ACT for emotional dysfunction following psychosis. 
Those in the ACT group demonstrated a greater increase in mindfulness skills and 
reduction in negative symptoms compared to TAU. When considering affective 
symptoms, a significantly greater proportion of the ACT group changed from being 
depressed at baseline to not being depressed at follow up. Furthermore, changes in 
mindfulness correlated with changes in depression, indicating the possibility of an 
association between the development of skills associated with increased psychological 
flexibility and a reduction in affective distress.  
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Depression in psychosis 
Depressive symptoms can emerge concurrent to the emergence of the psychosis, or 
can develop following a psychotic episode (Birchwood et al., 2000; Kuipers, 2005). 
Evidence indicates that the experience of depression is a major factor contributing to 
poorer quality of life amongst individuals with psychotic disorders generally (Saarni et 
al., 2010) and schizophrenia specifically (Meijer et al., 2009; Narvaez et al., 2008). 
Birchwood et al., (2000) reported that individuals with depression and lower self-esteem 
had auditory hallucinations of greater severity, more intensely negative in content and 
were more distressed by them. In addition, individuals with elevated depression had 
more negative evaluations about themselves and others, had persecutory delusions of 
greater severity and were more pre-occupied and distressed by them. Iqbal et al., 
(2000) reported that cognitive appraisals of psychosis involving loss of social role and 
shame predicted those who later developed post-psychotic depression. Depression in 
non-psychosis populations has also been associated with both internal (Tagney et al., 
1995) and external shame (Gilbert et al., 1996). External shame relates to evaluations 
of those aspects we believe others would reject or attack. Internal shame refers to 
negative self cognitions of our own attributes, personality and behaviour (Gilbert, 2002). 
Comparatively little research to date has investigated the role of internal shame in 
depression experienced by individuals with psychosis. From an ACT perspective, the 
way an individual relates to and responds to negative self-thoughts is more important 
than the actual content of these thoughts. This study seeks to explore the possibility that 
psychological flexibility might be associated with negative self-cognitions and internal 
shame in depression. 
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Emotion regulation and psychosis 
According to Livingston et al., (2009), the emotional experiences of individuals who 
experience psychosis has, until recently, been a neglected area of research. This may 
be as a result of a historical divide between the neuroses and psychosis (Freeman & 
Garety, 2003). However, the role of emotion in psychosis is now being increasingly 
recognised.  Livingston et al., (2009) suggested that there is an interaction between 
emotional dysfunction and psychotic symptoms. In order to regulate emotions, 
individuals who develop psychosis may rely on suppression of emotions and the 
directing of the individual’s resources and attention towards symptom experiences. 
Therefore, the role of emotion dysregulation may be important in the formation and 
maintenance of psychosis (Livingston et al., 2009). When considering an ACT 
conceptualisation of psychological distress, an unwillingness to stay in contact with 
internal experiences may reinforce a non-accepting and judgmental stance towards 
emotion experience (Gratz et al., 2010).  Research indicates that control or suppression 
of unwanted internal experiences may actually increase the frequency, severity and 
accessibility of these experiences (Gratz et al., 2010; Hayes et al., 2006). These 
paradoxical effects indicate a functionality of emotional experience, suggesting that 
adaptive emotion regulation may involve the ability to maintain awareness and 
understanding of emotional experience rather than directly controlling the emotions 
themselves. 
The conceptual overlap between psychological flexibility and emotion regulation skills 
include a willingness to notice and be aware of emotional experiences as well as the 
ability to engage in values-based and goal directed behaviours, as opposed to engaging 
in behaviours directed at suppressing or avoiding difficult emotional states. This study 
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explores the possible overlap between skills associated with psychological flexibility and 
skills associated with emotion regulation. To the knowledge of the author, this is the first 
time that the Difficulties in Emotion Regulation Scale (DERS) (Gratz & Roemer, 2004) 
has been used to explore emotion regulation in psychosis.  
Cognitive defusion 
Cognitive defusion involves encouraging a person to notice their thoughts, and to see 
them as hypotheses rather than objective facts about the world (Luoma & Hayes, 2009). 
This ACT technique attempts to reduce the believability and behavioural impact of 
distressing thoughts, not by focussing on attempts at suppression, debate or testing out, 
but by an emphasis on seeing thoughts as thoughts (Luoma & Hayes, 2009). Masuda et 
al., (2004) reported that a one session cognitive defusion technique reduced both the 
discomfort and believability of a self-relevant negative thought to a significantly greater 
extent than did a thought suppression and distraction condition in undergraduate 
students. Furthermore, Bach and Hayes (2002) compared a three-hour long version of 
ACT over five sessions (in which cognitive defusion was the main component) to 
treatment as usual in a psychotic sample. This brief ACT intervention produced a 
decrease in the believability of symptoms, but not in their frequency. 
Rationale  
Exploring the effect that ACT-related processes, such as Defusion, can have on distress 
related to negative self-cognitions may help refine interventions aimed at reducing 
depression occurring in the context of psychosis. In addition, the exploration of 
therapeutic applications provides the opportunity to test out the theoretical 
underpinnings of how changes in distress may occur in the context of reducing 
experiential avoidance and increasing psychological flexibility. Furthermore, 
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investigating possible associations that depression has with psychological flexibility, 
emotion dysregulation and internal shame, provides the opportunity to explore the 
applicability of the ACT conceptualisation of psychological flexibility in the treatment of 
low mood in psychosis; as well as provide further insight into the predisposing and 
perpetuating psychological processes related to distress in psychosis. 
 
Research aims 
The study aimed to: 
i. Investigate the effectiveness and acceptability of a defusion intervention aimed 
at increasing psychological flexibility and reducing distress associated with 
negative self-cognitions. 
ii. Investigate how depression was associated with internal shame, psychological 
flexibility and emotion dysregulation in psychosis. 
 
Hypotheses 
1a. Individuals randomised to receive a defusion intervention will have a significantly 
greater decrease in subjective units of distress associated with negative self-cognitions 
compared to those randomised to the control arm of the study. 
1b. Engaging in a defusion exercise will be acceptable to individuals with psychosis who 
are experiencing low mood, as measured by a satisfaction questionnaire. 
2. Higher levels of depression will be associated with increased shame / self-stigma, 
decreased psychological flexibility and greater emotion regulation difficulties. 
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Method 
Design 
Phase 1: Investigating the acceptability and effectiveness of a defusion intervention for 
negative self-cognitions. 
The principle aim of phase 1 was to investigate whether a one session defusion 
intervention reduced distress associated with negative self-cognitions. This was a 
parallel between-group, randomised controlled study. Participants were randomly 
assigned to either a defusion intervention or control condition using a computerised 
randomisation paradigm (www.randomizer.org).  The control arm of the study consisted 
of a block design task that served as a neutral cognitive distraction task. 
Phase 2: Investigating the associations that depression has with internal shame, 
psychological flexibility and emotion dysregulation in psychosis.  
An exploratory correlational analysis was employed to investigate associations between 
depression, internalised shame, psychological flexibility and emotion regulation. 
Ethics 
The West of Scotland Research Ethics Committee granted approval for the study (See 
approval documentation in Appendix 2.2). 
Sample size 
White et al., (2011) examined the association between psychological flexibility and 
depression (as assessed by the Depression subscale of the HADS) in a psychosis 
sample and found a correlation of r = -0.55. GPower v3.1.2, (Erdfelder et al., 1996), a 
general power analysis program, was used to conduct a power calculation for bivariate 
65 
 
correlational design on the basis of this correlation coefficient (with power set at 0.80 
and alpha set at 0.05). This analysis indicated that a sample size of 19 would have a 
power of 0.82.   
Masuda et al., (2004) compared the effect of a cognitive defusion task on distress with 
self relevant negative thoughts compared to a distraction task. The authors reported the 
treatment and control means of a small sample, but did not report the effect size or 
standard deviations necessary to calculate the power of the study. As such, this pilot 
phase of the current study will determine power levels useful for future studies of this 
type of brief intervention.  
Participants 
Participants aged between 18-65 years old were eligible for inclusion. Participants were 
required to meet the ICD-10 (WHO, 1992) criteria for Schizophrenia, Schizoaffective or 
Schizotypal disorders or Bipolar disorder with psychotic features. Individuals who had a 
learning disability, brain injury, organic brain disease, or substance use disorder (as 
stipulated by ICD-10 criteria) were not eligible for participation in the study. Individuals 
judged by the clinical team responsible for their care to lack the capacity to consent to 
participation and individuals experiencing acute distress or active suicidality were not 
included in the study. Participants were recruited from Community Mental Health and 
Psychiatric rehabilitation settings within NHS Greater Glasgow and Clyde. Participants 
were identified by members of the clinical team responsible for their care and were 
referred to the study on the basis that the potential participant was experiencing 
depression in the context of their psychosis. Potential participants were provided with a 
Participant Information Sheet (see Appendix 2.3) and those who expressed interest in 
participating were provided with a face-to-face appointment in which any further 
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questions about participating were answered. They were then invited to provide written 
consent should they wish to participate (see Appendix 2.3 for consent form). 
Measures 
The Positive and Negative Syndrome Scale (PANSS) (Kay & Opler, 1987). The PANSS 
is a 30-item clinician rated scale used to assess the presence and severity of psychotic 
psychopathology. The scale assesses positive and negative symptoms as well as global 
psychopathology. Good inter-rater reliability and validity have been reported (Bell et al., 
1992). The chief investigator (RF) received training in PANSS administration and 
scoring from research clinicians who were highly experienced in using the PANSS in 
research settings. This involved rating observed role-plays of full PANSS interviews and 
having scores calibrated with the trainer and any discrepancies discussed.  
Difficulties in Emotion Regulation Scale (DERS) (Gratz & Roemer, 2004). The DERS is 
a 36-item self report measure that assesses an individual’s typical levels of emotion 
regulation difficulties across specific dimensions of emotion regulation (see Appendix 
2.8). Individuals are asked to rate how often a statement applies to them ranging from 1 
to 5, with 1 being “almost never” and 5 being “almost always”.  The subscales of 
emotion regulation are (a) non-acceptance of emotional responses; (b) difficulties 
engaging in goal directed behaviours when distressed; (c) difficulties controlling 
impulsive behaviour when distressed; (d) lack of emotional awareness; (e) limited 
access to emotion regulation strategies perceived as effective and (f) lack of emotional 
clarity. The DERS score provides an overall score as well as subscale scores related to 
greater difficulties in emotion regulation. The DERS has been found to have high 
internal consistency with both clinical (Gratz et al., 2008) and non-clinical samples 
(Gratz & Roemer, 2004). 
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The Beck Depression Inventory – Second Edition (BDI- II) (Beck, Steer & Brown, 1996). 
The BDI-II is a widely used measure of depressive symptoms and is considered a valid 
and reliable instrument for depression screening in general and clinical populations 
(Beck et al, 1996). The BDI-II yields a single score with standardized ranges indicating 
no/minimal depressive symptoms to mild, moderate or severe depressive symptoms. 
Items in the BDI-II reflect cognitive, affective, and somatic symptoms of depression. 
The Internalised Shame Scale (ISS) (Cook, 1994). The ISS assesses feelings of 
inferiority, worthlessness, inadequacy, and alienation (Cook, 1994; 2001).  The ISS 
requires individuals to rate each of the 30 items on a five point Likert scale ranging from 
“Never” to 4 “Almost Always”. There are 24 negatively worded items that measure 
shame and 6 items that measure self-esteem. Higher scores on both scales indicate 
high shame and poorer self-esteem. The ISS scales demonstrate high temporal stability 
and high internal consistency (Rosario & White, 2006).  
Acceptance & Action Questionnaire (AAQ-II) (Bond et al., 2010). The AAQ-II is a 7-item 
revision of the original 9-item AAQ (Hayes, 2000), (see Appendix 2.7). It is a self-report 
measure of experiential avoidance, negative evaluations of internal experience and 
psychological acceptance; collectively described as ‘‘psychological flexibility’’. 
Psychological flexibility is a core construct of the ACT model of psychopathology (Hayes 
et al., 2006). The AAQ-II has been shown to have good convergent validity (Bond et al., 
2007). Lower scores on the AAQ-II indicate greater psychological flexibility, and 
therefore lower vulnerability to developing psychopathology.  
Client Satisfaction Questionnaire: A 5 item self-administered questionnaire (see 
Appendix 2.4) specifically developed for this study and based on the Client Satisfaction 
Questionnire-8 item version (CSQ-8) by Attkisson and Greenfield (2004) was completed 
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by individuals randomised to the defusion group. The items enquire about the 
participants’ opinions about the intervention they received. Answers are based on a four 
point scale (1= No, definitively not; 2= No, not really; 3= Yes, generally; 4= Yes, 
definitively) and examples of questions include “Has the brief intervention you received 
helped you to deal more effectively with any problems?” and “If you were to seek help 
again, would you consider engaging in a similar type of intervention/treatment?”. The 
questionnaire score ranges from 5 to 20, with higher values indicating higher 
satisfaction. 
Idiographic measures of distress and believability associated with a negative self-
cognition (identified through the administration of the ISS) were assessed before and 
after the brief intervention (see Appendix 2.5).  Participants were asked “When 
considering the negative self thought how would you rate your distress on a scale of 1-
10? (1 being no distress and 10 being most distressed)” and  “How believable is the 
negative self thought on a scale of 1-10? (1 not believable and 10 being very 
believable)”. 
 
Procedure 
Session 1 – This session was 60-80 minutes in duration. This included the completion 
of the: Positive and Negative Syndrome Scale (PANSS), Acceptance & Action 
Questionnaire (AAQ-II), The Beck Depression Inventory – Second Edition (BDI-II) and 
the Difficulties in Emotion Regulation Scale (DERS). Following the completion of 
session 1, participants were randomised to either defusion or control group. 
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Session 2 –This session was 60-80 minutes in duration. Participants completed the 
Internalised Shame Scale (ISS) to assess and identify individual negative self-
cognitions. Participants then rated a selected negative self-cognition (guided by an item 
rated as 4 on the ISS, which is the maximum possible score for an item) for: a) Distress 
and b) Believability using the idiographic measures described earlier. Participants then 
completed 30 minutes of either a defusion intervention or a collaborative block design 
task with the chief investigator (RF) (see Appendix 2.5. for details of the cognitive 
defusion exercise and block design task). Participants then re-rated the negative self 
cognition for subjective distress and believability. Of those in the defusion group that 
consented to being audio recorded (n=2), session 2 was independently rated for 
adherence to treatment modality. Individuals randomised to the defusion intervention 
were asked to complete the Client Satisfaction Questionnaire (see Appendix 2.4) 
anonymously.  
 
Analytic strategy 
Analyses were conducted using SPSS-18. Spearman’s rho correlation analyses were 
conducted to investigate associations between shame, emotion regulation and 
psychological flexibility with depression. Bonferroni adjustment of alpha was applied to 
reduce the risk of Type I error. Due to the exploratory nature of the study and the 
conservative Bonferroni correction, results significant at the p<0.05 and p<0.01 level 
before Bonferroni correction are reported as such, in order to highlight possible trends in 
the data. Kolmogorov-Smirnov tests revealed the variables in the randomised controlled 
pilot were normally distributed; therefore, paired sample t-tests were used to investigate 
change in believability and distress within groups pre and post intervention. 
Independent group t-tests were used to compare differences in change scores between 
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the defusion and control groups. Non-parametric Mann-Whitney U tests were used to 
assess differences between the depressed and non-depressed groups on outcome 
measures as these were not normally distributed. 
Results 
Demographics 
A total of 23 were referred to the study, all of those referred met the inclusion criteria. 
Five of those referred chose not to participate, indicating a 78% consent rate. Two (8%) 
withdrew after providing consent and one (4%) participant (randomised to control) 
discontinued after the first session. This resulted in a total of 16 participants, of which 15 
(94%) completed both sessions. Baseline demographic characteristics for each group 
are presented in Table 1. Mann-Whitney U test showed that there were no significant 
differences between the groups. Means and standard deviations for all outcome 
measures are presented in Table 2. The BDI-II mean for the total sample was 
23.37(10.8). 
 
[INSERT TABLE 1 NEAR HERE] 
 
[INSERT TABLE 2 NEAR HERE] 
 
 
Correlations between process and outcomes measures 
See Table 3 for a summary of Spearman’s rho correlations between process and 
outcome measures. BDI-II scores were positively correlated with the: AAQ-II scores, 
(rho=.68, n=14, p=.007), the ISS (rho=.75, n=14, p=.002) and the DERS Total score 
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(rho=.84, n=14, p<.001). The AAQ-II correlated positively with the ISS (rho=.81, n=13, 
p<.001) and DERS Total score (rho=.80, n=13, p<.001). Some DERS subscale scores 
correlated strongly with the AAQ-II including difficulties associated with Non-Acceptance 
(rho=.62, n=13, p=.002), Emotional Clarity (rho=.83, n=13, p<.001) and Emotion 
Regulation Strategies (rho=.85, n=13, p<.001).  The ISS was also strongly positively 
correlated with the DERS Total score, (rho= .83, n=13, p<.001). The aforementioned 
correlations marked in italic remained significant after the alpha level was adjusted. 
 
[INSERT TABLE 3 NEAR HERE] 
 
Comparison of caseness for depression 
Caseness for depression was defined as a BDI-II score of 15 or above, as used by 
Birchwood et al., (2000) and White et al., (2007). In the current sample N=13 (81%) met 
caseness for depression.  Mann Whitney U tests revealed there was no significant 
difference between the caseness and non caseness groups in AAQ-II scores (Z=-1.32, 
p=.18). There was, however, a significant difference in ISS scores (Z=-2.1, p=.03) and 
DERS (Z=-1.94, p=.05) scores between the groups. (See Table 4 for median and inter-
quartile ranges for depressed and non depressed groups). 
 
[INSERT TABLE 4 NEAR HERE] 
 
Within group effects on distress and believability of negative self cognitions 
Paired samples t-tests showed that the decrease in ratings of distress following 
defusion intervention from pre intervention (M=7.38, SD=1.68) to post intervention 
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(M=6.13, SD=1.72) neared significance (t(7)= 2.11, p=.072, d= .73) and indicated a 
large within group effect size. A decrease in ratings of believability following defusion 
intervention from pre intervention (M=9.00, SD=0.92) to post intervention (M=8.38, 
SD=1.92) was not significant (t(7)= 1.25, p=.25, d= .41) and indicated a small within 
group effect. The control group means scores for distress (M=6.00, SD= 2.6) and 
believability (M=7.67, SD=3.0) remained the same pre and post intervention.  
 
Between group effects on distress and believability of negative self cognitions 
T-tests comparing change scores in distress between the defusion and control groups 
neared statistical significance with a large effect size (t(12)= -2.11, p= 0.07, d= 1.21). 
Change scores between defusion and control groups on believability were not 
statistically significant but indicated a large effect size (t(12)= - 1.23, p 0.25, d= 0.71). 
 
Acceptability of ACT intervention 
A total of five out of a possible eight client satisfaction questionnaires were returned to 
the researcher. Appendix 2.6 shows the frequencies and percentages of participant 
responses across the five questions. When responding to whether the brief intervention 
had been helpful, N=5 (100%) selected Yes. N= 4 (80%) of the sample were either 
satisfied or very satisfied with the intervention they received and N=1 (20%) reported 
that they were mildly dissatisfied. N=3 (60%) fed back that the brief intervention helped 
them to deal more effectively with problems. N=5 (100%) indicated that they would 
consider engaging in a similar type of intervention in the future and that they would 
recommend the brief intervention to a friend.  
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Discussion 
The primary aim of this study was to explore the feasibility and acceptability of a brief 
defusion intervention for distressing self-cognitions in individuals presenting with low 
mood in psychosis.  This randomised control pilot has highlighted that referral pathways 
could be established with Community Mental Health and Rehabilitation Teams within 
the NHS. Furthermore, clinicians were able to identify individuals with psychosis 
presenting with low mood. The BDI-II mean for the total sample (M=23.37, SD=10.8) 
indicated this sample presented with moderate levels of clinical depression in 
accordance with criteria provided by Beck et al., (1996). Results indicated that 
individuals presenting with psychosis and mood difficulties were motivated to engage 
and that participation in the research was well tolerated.  The responses indicate that 
the defusion intervention as a treatment was very much acceptable to those participants 
and perceived as helpful. 
 
When comparing the effect of defusion intervention on negative self cognitions, there 
was a trend approaching significance indicating that the defusion group, relative to 
control, had a greater decrease in distress. There was no statistically significant 
difference between defusion and control group in the reduction of believability of 
negative self cognitions. There was a large within group effect in the defusion group in 
the reduction of distress associated with the negative cognition and a small within group 
effect size in the defusion group in the reduction of believability. This is a promising 
finding from what was a single session defusion intervention.  The aim of cognitive 
defusion is to support individuals to develop skills in becoming aware of their internal 
experiences without becoming entangled in them. It would make sense that the 
defusion intervention would prompt a decrease in distress associated with the negative 
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self cognition, with any change in the intensity of the belief being secondary to 
increased awareness and not through direct appraisal of the accuracy of the belief. 
 
A secondary aim of this study was to explore the associations that levels of depression 
had with internal shame, psychological flexibility and emotion regulation difficulties in 
psychosis. The exploration aimed to provide further insight into the possible 
predisposing and perpetuating cognitive process related to depression in psychosis and 
to examine the applicability of the ACT conceptualisation of psychological flexibility in 
the treatment of low mood in psychosis. Psychotic symptom severity, as measured by 
the PANSS was not correlated with depression, internal shame, psychological flexibility 
or emotion regulation difficulties. This lack of association corroborates findings from 
White et al., (2012) in which the PANSS was not associated with depression in a 
psychosis sample.  
 
Correlational analyses indicated a trend in which increased depression in psychosis 
was associated with lower psychological flexibility and higher internalised shame: 
highlighting that psychological flexibility may decrease, and shame-based cognitions 
may increase, as depressive symptoms worsen. Future research, with a larger sample 
size to increase power, is required to investigate these associations further. The 
association between depression and psychological flexibility, indicated in these results, 
corresponds to findings reported by White et al., (2012) who found a negative 
correlation in depression in psychosis with both psychological flexibility and mindfulness 
skills.  
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Confirming hypothesis 2, higher levels of depression in psychosis were found to 
correlate with the DERS suggesting difficulties in emotion regulation were associated 
with increased depressive symptoms. The AAQ-II correlated strongly with the DERS 
total score as well as the DERS subscales measuring Emotional Clarity and Emotion 
Regulation Strategies. This research has highlighted the existence of shared conceptual 
features in skills associated with psychological flexibility and skills associated with 
emotion regulation in psychosis. This is the first time, to the knowledge of the author, 
that the DERS has been used in psychosis related research. Further research is 
required to explore what it is about the concepts measured by the DERS that are 
associated with depression in psychosis. 
 
Internalised shame positively correlated with both psychological flexibility and emotion 
regulation difficulties indicating that as cognitions associated with internal shame in 
psychosis increase, psychological flexibility and emotions regulation abilities decrease. 
Between group comparisons indicated that the depressed group had increased scores 
for internal shame and difficulties with emotion regulation that were statistically 
significant compared to the non-depressed group. Future research is required to employ 
larger samples of individuals with psychosis to further test the associations explored in 
phase 2. 
 
Limitations 
This study had a number of limitations. The number of participants (n=16) recruited was 
small and not in accordance with the n=19 indicted in the power analysis. However, 
large within group effect sizes were noted in the reduction of distress and believability 
following the defusion intervention despite the small sample. The small sample size also 
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has implications for the exploratory analyses, with the possibility of an increased risk of 
Type II errors following the Bonferroni correction of alpha used in light of the multiple 
comparisons (Garamszegi, 2006). This limits the generalisability of the findings from this 
exploratory analysis.  The results of the exploratory correlational analysis conducted in 
the current research can be used to inform future research exploring the ways in which 
psychological flexibility, acceptance and cognitive defusion may be associated with 
negative self cognitions and depression in psychosis. 
 
The participants in the study had a range of psychiatric diagnoses and diagnostic 
interviews were not conducted, instead case file diagnoses were relied upon. This 
sample does, however, represent the heterogeneous nature of clinical samples and 
supports the ecological validity of the research. Time limits to recruitment for this study 
meant that follow-up was not investigated. A follow up period would have been 
beneficial to establish if within and between group differences were maintained.  
 
Clinical Implications 
This was an exploratory study investigating the potential suitability, effectiveness and 
acceptability of a defusion intervention for negative self-cognitions in psychosis. This 
study has highlighted that the sample of individuals presenting with psychosis and mood 
difficulties were motivated to engage and that intervention aimed at developing skills in 
cognitive defusion was well tolerated. The findings also indicate an association between 
the experience of negative self cognitions in psychosis and difficulties with emotion 
regulation and psychological flexibility. This association may contribute to the 
development and maintenance of low mood in psychosis. This has implications for the 
conceptualisation and treatment of low mood in psychosis; interventions aimed at 
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developing skills associated with emotion regulation and psychological flexibility may 
promote a reduction in affective distress linked with negative self cognitions.  
 
Implications for future research 
A future randomised control trial investigating the effect of ACT intervention on distress 
associated with negative and shame-based cognitions would provide more evidence as 
to the effectiveness of such an approach for low mood in psychosis. Follow up would 
also be important to explore the maintenance of any therapeutic gains. Future research 
could employ the Cognitive Fusion Questionnaire (CFQ) to investigate whether 
cognitive fusion is associated with internal shame and depression. Gillanders et al., 
(2010) report that the CFQ more specifically explores thoughts, believability and 
perspective taking compared to more general measures of psychological flexibility 
(AAQ-II) which more broadly explores memories, judgements, emotions and action.   
 
The current research has highlighted an association between internal shame and low 
mood in this population. Future research exploring internal shame in a larger sample 
would be merited as it may provide more information on the relationship between 
internalised shame (self stigma) and the maintenance of low mood in psychosis. 
Furthermore, the current research has indicated an association between psychological 
flexibility and emotion regulation abilities in this population. Future research further 
exploring the measurement of these two concepts may shed more light on their possible 
associations. For example it may be useful to investigate the association between the 
DERS with other ACT-related measures such as the CFT in this population.  
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Conclusion 
The present study highlights that a brief defusion intervention may be effective in 
reducing distress associated with negative self-cognitions in individuals experiencing 
depression in psychosis.  Further investigation is warranted in the exploration of 
associations between experiential avoidance and psychological flexibility with negative 
self-cognitions and depression in psychosis; to further inform and refine interventions 
aimed at reducing affective distress and depression in psychosis.  
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Table 1. Participant Demographics        
    Randomised      Randomised 
to Defusion       to Control  
    N= 8                    N=8 
             
Gender Male 5 (62.5%) 6 (75%) 
Female 3 (37.5%) 2 (25%) 
Mean Age (SD) 45.6 (12.4) 42 (4.9) 
Relationship Status Single 6 (75%) 7 (87.5) 
In a relationship 0 (0%) 0 (0%) 
Married 1 (12.5%) 1 (12.5%) 
Separated / Divorced 1 (12.5%) 0 (0%) 
Education Secondary Education 5 (62.5%) 8 (100%) 
Higher Education 3 (37.5%) 0 (0%) 
Employment Status Employed 1 (12.5%) 1 (12.5%) 
Unemployed 7 (87.5%) 7 (87.5%) 
Ethnicity White British 8 (100%) 8 (100%) 
Diagnosis Schizophrenia (F20) 6 (75%) 7 (87.5%) 
Schizophrenia with Depression (F20.4) 1 (12.5%) 0 (0%) 
Schizo-affective Disorder Not Specified 
(F25.9) 
0 (0%) 1 (12.5%) 
Bipolar Disorder Mania and psychosis 
(F31.2) 
1 (12.5%) 0 (0%) 
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Table 2. Means (SD) of outcome measures for all participants (n=16) 
Outcome measure 
Symptom Measures 
PANSS Total                                87.81 (15.1) 
PANSS Positive                                19.63 (6.0) 
PANSS Negative                                24.13 (7.3) 
PANSS General                                43.88 (7.0) 
BDI-II                                23.37 (10.8) 
Measures of psychological flexibility and shame 
AAQ-II                                29.43 (11.1) 
DERS Total                                99.79 (29.3) 
DERS Non-acceptance of Emotional Responses                                16.21 (4.4) 
DERS Difficulties Engaging in Goal-Directed                                16.29 (5.5) 
DERS Impulse Control Difficulties                                15.00 (4.5) 
DERS Lack of Emotional Awareness                                16.36 (4.8) 
DERS Limited Access to Emotion Regulation Strategies                                22.64 (8.1) 
DERS Lack of Emotional Clarity                                13.29 (4.6) 
ISS Shame                                42.50 (17.3) 
ISS Self Esteem                                11.50 (4.5) 
AAQ-II = Acceptance and Action Questionnaire; BDI-II = Beck Depression Inventory 2nd edition; DERS= 
Difficulties in Emotion Regulation Scale; ISS = Internalised Shame Scale; PANSS = Positive and 
Negative Syndrome Scale. 
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Table 3. Spearman’srho correlations between process and outcome measures 
 
                       Process Measures 
 AAQ-II DERS       
Total 
DERS    
Non 
Acceptance 
DERS 
Goals 
DERS 
Impulsivity 
DERS 
Emotional 
awareness 
DERS 
Emotion 
regulation 
DERS 
Emotion 
clarity 
 
Outcome                                                                                                                                                               
Measures 
 
BDI-II 
 
0.68b 
 
0.84*** 
 
0.70b 
 
0.67b 
 
0.82*** 
 
0.78*** 
 
0.83*** 
 
0.59a 
ISS-Shame 0.81*** 0.82*** 0.79*** 0.67b 0.70b 0.62a 0.84*** 0.81b 
PANSS 
Positive 
subscale 
-0.08          -0.07 0.24 0.25 -0.08 -0.13 -0.11 -0.18 
PANSS 
Negative 
subscale 
0.00          -0.21 0.22 0.04 0.14 0.28 0.11 0.20 
aSignificant at the p < 0.05 level (2-tailed); bSignificant at the p < 0.01 level (2-tailed);  
*** Significant at the Bonferroni adjusted alpha level of 0.00156 
 
AAQ-II = Acceptance and Action Questionnaire; BDI-II = Beck Depression Inventory 2nd edition; DERS= 
Difficulties in Emotion Regulation Scale; ISS = Internalised Shame Scale; PANSS = Positive and 
Negative Syndrome Scale. 
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Table 4. Median and Inter-quartile ranges for depressed and non-depressed groups. 
 
Depressed         Non-Depressed 
N=13                  N=3 
 
Outcome Measures 
BDI-II                                                              
 
 31(13)              3(9) 
ISS      48(21)              18(12) 
PANSS Positive Subscale                                     18(8)                 24(18)                            
PANSS Negative Subscale                                    24(7)                28(26) 
 
Process Measures 
DERS 
AAQ-II                          
 
115(51)             75(27) 
29(17)               25(15) 
AAQ-II = Acceptance and Action Questionnaire; BDI-II = Beck Depression Inventory 2nd 
edition; DERS= Difficulties in Emotion Regulation Scale; ISS = Internalised Shame Scale; 
PANSS = Positive and Negative Syndrome Scale. 
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Abstract 
In this account I reflect upon how my observations of service user involvement during a 
specific placement have contributed to my professional development. Throughout I 
consider how I might support meaningful service user involvement in the future. The 
reflection is structured and guided by Carr’s (1995) Positive Practice Model, an 
integrative approach often used to provide consultation to families. I document my 
conceptualisations of how the team functions and integrates with service users.  Policy 
and practice standards informed by the social and political context of service user 
involvement are also considered.  
The account concludes with discussion around my endeavour to integrate service user 
involvement principles within my clinical practice in the future.  Furthermore, I 
acknowledge that the reflective process undertaken has also allowed me to consider 
how, as a newly qualified clinical psychologist, I might facilitate discourse within 
systems that can affect progress and change.  
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Abstract 
In this account I reflect upon my observations of the treatment of psychosis whilst on 
placement and explore how my reflections may inform my development as a clinical 
psychologist. I consider how my experiences may influence the ways in which I will 
support the integration of a psychological response to psychosis in the future. The 
reflection is guided by the framework for reflective practice developed by Rolfe et al. 
(2001). I document my conceptualisations of how CMHTs respond to psychosis and the 
challenges to integrating a psychological perspective within these service structures. 
The account concludes with discussion around my commitment to supporting the 
integrated delivery of evidence based treatment for psychosis, and the challenges I may 
be required to respond to.   
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Appendix 1.1 Matrix of Quality Rating Scores 
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a) Title and abstract 
             
1. Identification as a randomised trial in the title? (Yes =1, No =0) 0 1 1 1 0 1 1 1 1 0 1 0 0 
2. Structured summary of trial design, methods, results, and conclusions 
in abstract? (Yes =1, No =0) 
0 1 0 1 0 0 0 0 1 0 0 0 0 
Total: 0 2 1 2 0 1 1 1 2 0 1 0 0 
b) Introduction 
             
1. Is the rationale for the trial clearly stated? (Yes =1, No =0) 1 1 1 1 1 1 1 1 1 1 1 1 1 
2. Is a systematic review relating to the treatment cited in the 
introduction?(Yes =1, No =0) 
1 1 1 1 1 1 1 1 1 1 1 1 1 
Total: 
 
2 2 2 2 2 2 2 2 2 2 2 2 2 
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c) Design 
             
1. Was the type of design (parallel group, multi-arm parallel, 
crossover, cluster, or factorial) stated? (Yes =1, No =0) 
1 1 1 1 1 1 1 1 0 1 1 1 1 
2. Was the research prospective (= 2), or cross-sectional (= 1)? 
No =0 
2 1 1 2 2 1 1 1 1 1 1 1 1 
3.    Was the unit of randomisation stated e.g. patient, GP practice or 
CMHT resource centre? (Yes =1, No =0) 
1 1 1 1 1 1 1 1 1 1 1 1 1 
Total: 4 3 3 4 4 3 3 3 2 3 3 3 3 
d) Participants 
             
1.     Was the inclusion criteria explicitly stated? (Yes =1, No =0) 1 1 1 1 1 1 0 1 0 1 1 1 1 
2.   Was the exclusion criteria explicitly stated?  (1 = Yes, 0 = no/the 
study had no exclusion criteria) 
1 1 1 1 1 0 0 1 1 1 1 1 1 
3. Is the sample a convenience sample (score 2), geographic 
cohort (score 5), highly selected sample e.g. volunteers/self-
referral/not stated (score 0)? 
N.B. Convenience sample e.g. clinic attendees, referred patients.  
Geographic cohort e.g. all patients eligible in a particular area. 
2 2 2 0 2 0 0 2 2 2 0 2 2 
4. Were analyses conducted comparing participants and those 
who refused to participate/dropped out? (Yes =1, No =0) 
1 0 0 1 0 0 0 0 0 0 0 0 0 
5. Were demographics of participants described? (Yes =1, No =0) 1 1 1 1 1 0 1 1 0 1 1 1 1 
6. Were baseline clinical characteristics of participants described? 
(Yes =1, No =0) 
0 1 1 1 0 1 1 1 1 1 1 1 1 
7. Were diagnoses of participants reported? (Yes =1, No =0) 1 1 1 0 1 1 0 1 0 0 0 0 1 
8. Were the diagnostic criteria explicitly stated (e.g. DSM-IV, ICD-
10)? (Yes =1, No =0) 
0 1 1 0 0 0 0 1 0 1 0 0 1 
9.    Were dates of recruitment and follow-up provided? (Yes =1, No =0)1 1 0 1 1 1 0 0 0 0 0 1 0 
Total: 
 
8 9 8 6 7 4 2 8 4 7 4 7 8 
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e) Study Setting 
             
1. Did the study report the country or city in which the research was 
conducted? (Yes =1, No =0) 
1 1 1 1 1 1 1 1 1 1 0 1 1 
2. Did the study report whether participants were recruited from primary, 
secondary and/or tertiary services? (Yes =1, No =0) 
1 0 1 1 1 0 1 1 0 1 1 1 1 
3. Was the study reported to be single site/multi-site?  
(Yes =1, Not reported =0) 
1 1 0 0 1 0 0 0 0 1 0 1 1 
Total: 3 2 2 2 3 1 2 2 1 3 1 3 3 
 
f) Methodology 
             
1. Were details about ethical approval for the study provided? 
(Yes =1, No =0) 
1 0 1 1 1 1 0 1 0 0 0 0 0 
2. Were objectives/hypothesis explicitly stated? (Yes =1, No 
=0) 
1 1 1 0 1 1 0 1 0 1 1 1 0 
3. How was the sample size determined? (0 = it was not/not 
reported, 1 = method reported) 
1 0 0 1 0 0 1 0 0 0 0 0 1 
4. Was this statistical power sufficient? (0 = no/not reported, 
1 = yes) 
1 0 0 0 0 0 0 0 0 0 0 0 0 
5. Were between group comparisons made? (0 = no/not 
reported, 1 = yes) 
1 1 1 1 1 1 1 1 1 1 1 1 1 
6. What methods were used to generate random sequence 
allocation? (0 = none/not reported, 1 = method appropriate 
and reported) 
1 1 0 1 1 1 0 1 1 0 1 0 0 
7. Was the method used to generate the random allocation 
sequence described? (0 = no/not reported, 1 = yes) 
1 0 0 1 1 1 0 1 1 0 1 0 0 
8. Does the paper state who generated the random allocation 
sequence? (0 = no/not reported, 1 = yes) 
1 0 0 1 0 1 0 0 0 0 1 0 0 
       9.    Were those completing outcome assessments blinded to group 
assignment? (0 = no/not reported, 1 = yes) 
1 0 1 0 0 1 0 0 0 1 0 0 0 
Total: 
 
9 3 4 6 5 7 2 5 3 3 5 2 2 
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g) Assessment 
             
1. Were psychiatric symptoms assessed with a reliable and valid 
measure? (Yes =1, No =0) 
1 1 1 1 1 1 0 0 0 0 1 1 1 
2. Was depression assessed with a reliable and valid measure?      
(Yes =1, No =0) 
1 1 1 1 1 1 1 1 1 1 1 1 1 
3. Was anxiety assessed with a reliable and valid measure?            
(Yes =1, No =0) 
1 1 0 1 1 1 0 0 1 0 1 1 1 
4. Was the medication that participants were taking reported? 
(Yes =1, No =0) 
0 4 0 0 0 1 0 0 0 1 0 0 0 
5.  What was the method of assessment? (Clinician Administered 
Diagnostic Interview = 4, Clinician Administered Self-report 
Checklist = 3, Self-report Symptom Checklist = 2, Postal Survey = 
1, None = 0)  
3 2 4 3 3 3 3 3 3 3 4 2 3 
6.   Was there an indication of who assessed patients i.e. their 
qualification and training on measures? (Yes =1, No =0) 
1 0 1 1 1 1 1 1 0 1 1 1 1 
Total: 7 9 7 7 7 8 5 5 5 6 8 6 7 
h) ACT intervention 
             
1. Were any of the following used as part of the intervention? (All 
six domains =3, More than one domain =2, One domain =1, None 
=0) 
(a) Defusion 
(b) Self as context/mindfulness of self 
(c) Creative hopelessness Explore the impact of previous 
efforts to control or avoid 
(d) Experiential Acceptance Out of session acceptance skills 
practice 
(e) Values & Goals 
(f) Committed Action 
3 3 3 3 3 2 3 3 3 3 2 3 0 
2. Were the possibility of deviations from the therapy protocol 
described together with the reasons for this? (Yes =1, Not 
discussed =0) 
0 0 0 0 0 0 0 0 0 0 0 0 0 
3. Was the control intervention described in sufficient detail? E.G. 
Was ‘treatment as usual’ actually described?     (Yes =1, No =0) 
1 1 1 1 1 0 1 1 1 1 1 1 1 
4. Was the location / site of the intervention reported? (Yes =1, No 
=0) 
1 0 1 0 1 0 1 0 1 1 0 1 1 
5. Were details provided about how the interventions were 
standardized? (Yes =1, No =0) 
1 1 1 1 1 0 0 1 1 0 0 1 0 
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6. Were details provided about how the adherence of therapists with 
the protocol was assessed? (Yes =1, No =0) 
 
1 1 1 0 1 0 1 1 1 1 1 0 1 
7. Was the intervention described with sufficient detail to allow for 
replication? (Yes =1, No =0) 
1 1 1 1 1 1 0 1 1 0 0 1 0 
8. Was the primary outcome measure defined? (Yes =1, No =0) 0 1 1 1 1 1 1 1 1 1 0 0 1 
9. Are secondary outcome measures defined? (Yes =1, No =0) 0 1 1 1 1 1 1 1 1 1 0 0 1 
10. Was information provided about the number of therapists 
that were used? (Yes =1, No =0) 
1 1 1 1 0 1 1 1 1 1 1 1 1 
11. (a) Were any ACT measures used? (Yes =1, No =0) 
      (b) Were they described? (Yes =1, No =0) 
      (c) Was the reliability and validity of each measure provided?                        
(Yes =1, No =0) 
1 
1 
1 
1 
1 
1 
1 
1 
0 
1 
1 
1 
0 
0 
0 
1 
1 
1 
1 
1 
0 
1 
0 
0 
1 
1 
1 
0 
1 
1 
1 
1 
1 
1 
1 
1 
0 
0 
0 
Total: 12 13 13 12 10 9 11 11 14 11 8 11 6 
i) Results 
             
1. Does the study state which primary outcome measure was 
used to calculate power? (0 = no/not reported, 1 = yes) 
0 0 1 1 0 0 0 0 0 0 0 0 0 
2. For each primary and secondary outcome; were the 
results for each group, and the estimated effect size and 
its precision (such as 95% confidence interval) reported? 
(0 = no/not reported, 1 = yes) 
1 1 1 1 1 1 0 0 0 0 1 0 1 
3. Were the analyses planned? (Yes =1, No =0) 1 1 1 1 1 1 1 1 1 1 1 1 1 
4. Was alpha modified in multiple statistical analyses to 
reduce the probability of type 1 error?  
(1 = Yes or Not applicable/No correlation, 0 = No/Not discussed) 
0 0 0 1 1 1 0 0 0 0 1 0 0 
5. Were the results of any other analyses performed, 
including subgroup analyses and adjusted analyses 
described, distinguishing pre-specified from exploratory? 
(Yes =1, No =0) 
1 0 0 1 1 1 1 0 1 1 1 0 0 
6. Were any possible adverse events associated with the trial  
discussed and reported? (Yes =1, No =0) 
1 0 0 0 0 0 0 0 0 0 0 0 0 
Total: 4 2 3 5 4 4 2 1 2 2 4 1 2 
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g) Discussion 
             
1. Were the results interpreted in light of the hypotheses? 
(Yes =1, No =0) 
1 1 1 0 1 1 1 1 0 1 1 1 1 
2. Were trial limitations discussed, addressing sources of 
potential bias, imprecision, and, if relevant, multiplicity of 
analyses? (Yes =1, No =0) 
1 1 1 1 1 1 1 1 1 1 1 1 1 
       3.     Was the generalisability discussed (external validity, 
applicability) of the trial findings? (Yes =1, No =0) 
1 1 1 1 1 1 1 1 1 1 1 1 1 
Total: 3 3 3 2 3 3 3 3 2 3 3 3 3 
Overall Total: 50 48 46 48 45 42 32 41 38 40 39 38 36 
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Appendix 1.2Measures used by the RCTs reviewed to assess anxiety and depression 
Measure Clinical cut off information Reference 
Beck Depression Inventory-BDI + 10 indicatescaseness for depression. 0–9: indicates minimal 
depression, 10–18: indicates mild depression, 19–29: indicates 
moderate depression, 30–63: indicates severe depression. 
Beck AT, Ward CH, Mendelssohn MJ, Erbaugh 
J. An inventory for measuring depression 
Archives of General Psychiatry 1961; 4:561-
571. 
Beck Depression Inventory second 
edition- BDI-II 0–13: minimal depression, 14-19 as ‘mild’, 20-28 as ‘moderate’, and 29-63 as ‘severe’. 
 
Beck, A. T., Brown, G., & Steer, R. A. (1996). 
Beck Depression Inventory II manual. San 
Antonio, TX: The Psychological Corporation. 
Beck Anxiety Inventory-  BAI A total score of 0-7 indicates minimal level of anxiety, 8-15 
indicates mild anxiety, 16-25 indicates moderate anxiety and 26-
63 indicates severe anxiety. 
Beck, A.T. & Steer, R.A. (1990). Manual for the 
Beck Anxiety Inventory. The Psychological 
Corporation. San Antonio: Tex. 
Brief Psychiatric Rating Scale- BPRS: 
Affect Subscale 
Leucht et al (2005) indicate severity ratings for BPRS total 
scores. The author could not obtain information regarding cut off 
scores or severity of the affect subscale specifically. 
Overall JE, Gorham DR (1962). The brief 
psychiatric rating scale. Psychological Reports 
1962 vol. 10, pp799-812 
Leucht.S, Kane,J. M.,  Kissling. W., Hamann, 
J.,  &Etschel. E. (2005) Clinical implications of 
Brief Psychiatric Rating Scale scores. British 
Journal of Psychiatry, 187:366-371. 
Depression Anxiety Stress Scales-DASS 
(21 item) 
A total score of 0-4 indicates minimal level of depression, 5-7 
indicates mild depression, 8-10 indicates moderate depression 
and 11-14 indicates severe depression, 15+ indicates extremely 
severe. 
A total score of 0-3 indicates minimal level of anxiety, 4-5 
indicates mild anxiety, 6-8 indicates moderate anxiety and 9-10 
indicates severe anxiety, 11+ indicates extremely severe. 
Lovibond, S. H., &Lovibond, P. F. (1995). 
Manual for the Depression Anxiety Stress 
Scales.Sydney: Psychology Foundation. 
Centre for 
EpidemiologicalStudiesDepressionScale- 
CES-D 
 
15-21, Mild to Moderate Depression. Over 21 the possibility of 
major depression. 
Radloff, L.S. (1977) ‘The CES-D scale: A self 
report depression scale for research in the 
general population’. Applied Psychological 
Measurement 1: 385-401. 
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Hospital Anxiety and Depression Scale-
HADS  
+ 8 on each subscale indicatescaseness for depression and 
anxiety. Normal range, 0-7; mild, 8-10; moderate, 11-14; severe, 
15-21. 
Zigmond, A.S., and Snaith, R.P. (1983). The 
Hospital Anxiety and Depression Scale. 
ActaPsychiatricaScandinavica 67, 361-370 
Pain Anxiety Symptoms Scale-Short 
Form-PASS 
The author could not obtain information regarding cut off scores 
or severity. 
McCracken. L. M., &Dhingra. L. (2007). A short 
version of the Pain Anxiety Symptoms Scale 
(PASS-20): Preliminary development and 
validity. Pain Research Management , 7, 45-50. 
Yale Brown Obsessive Compulsive 
Scale- Y-BOCS 
 
A total score of 0–7 is normal, 8–15 is mild, 16–23 is moderate, 
24–31 is severe and 32–40 is extreme. Scores in the mild range 
or above is considered as clinical. 
 
 
Goodman W. K., Price, L. H., Rasmussen, S. 
A., Mazure, C., Fleischmann, R. L., Hill, C. L., 
Heninger, G. R., &Charney, D. S. (1989). The 
Yale-Brown Obsessive Compulsive Scale: I. 
Development, Use, and Reliability. Arch Gen 
Psychiatry, 46(11), 1006-1011. 
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Reference management software 
This journal has standard templates available in key reference management 
packages EndNote (http://www.endnote.com/support/enstyles.asp) and Reference 
Manager (http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing 
packages, authors only need to select the appropriate journal template when preparing 
their article and the list of references and citations to these will be formatted according to 
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Text: Citations in the text should follow the referencing style used by the American 
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2710, Hyattsville, MD 20784, USA or APA, 3 Henrietta Street, London, WC3E 8LU, UK. 
List: references should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same author(s) in the same 
year must be identified by the letters 'a', 'b', 'c', etc., placed after the year of publication. 
Examples: 
Reference to a journal publication: Van der Geer, J., Hanraads, J. A. J., & Lupton, R. A. 
(2010). The art of writing a scientific article.Journal of Scientific Communications, 163, 51–59. 
Reference to a book: 
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supply 'stills' with your files: you can choose any frame from the video or animation or 
make a separate image. These will be used instead of standard icons and will personalize 
the link to your video data. For more detailed instructions please visit our video instruction 
pages at http://www.elsevier.com/artworkinstructions. Note: since video and animation 
cannot be embedded in the print version of the journal, please provide text for both the 
electronic and the print version for the portions of the article that refer to this content. 
Supplementary data 
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Supplementary files supplied will be published online alongside the electronic version of 
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Dr Ross White       Date 12th August 2011 
Clinical Research Fellow/Principle Clinical   Your Ref 
Psychologist      Our Ref 
University of Glasgow      Direct line 01412112123 
Academic Unit of Mental Health & Well-being  Fax  0141 211 1847 
Gartnavel Royal Hospital     E-mail Liz.Jamieson@ggc.scot.nhs.uk1055 
Great Western Road 
Glasgow G12 OXH 
 
 
Dear Dr White 
Study title:   Experiential avoidance in Psychosis: Associations with 
emotiondysregulation and depression? 
REC reference:  11/AL/0380 
 
Thank you for your letter of 02 August 2011, responding to the Committee's request forfurther 
information on the above research and submitting revised documentation. 
 
The further information was considered in correspondence by a sub-committee of the REC.A list of 
the sub-committee members is attached. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below. 
 
Ethical review of research sites 
 
NHS sites 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see "Conditions of the favourable opinion" below). 
 
Conditions of the favourable opinion 
The favourable opinion is subject to the following conditions being met prior to the start of 
the study. 
 
 
 
Appendix 2.3: Participant information sheet, consent form and poster 
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A study of experiences of difficult emotions and low mood in Psychosis 
 
Contact:  Rebecca Frost 
Academic unit of mental health and well-being, 
Gartnavel Royal Hospital, 1st Floor, Admin Building, 
University of Glasgow, Glasgow G12 0XH 
Email: r.frost.1@research.gla.ac.uk 
 
Participant Information Sheet  
 
I would like to invite you to take part in a research study. My name is Rebecca Frost, I am a 
trainee Clinical Psychologist. I am interested in learning about people’s experience of 
psychosis and how it may affect their feelings and mood.  
Before you decide if you would like to take part it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. I advise that you take at least 24 
hours to decide whether to take part in the study. 
 
What is the research about? 
The research is being carried out to help us learn more about the experience of psychosis.  
This research aims to find out more about psychosis and how it may affect emotions and 
mood. Research suggests that the experience of psychosis may make some people 
vulnerable to experiencing low mood (sometimes called depression) and negative beliefs 
about self. The study will also assess if a brief (one session) Acceptance and Commitment 
Therapy intervention is of benefit for treating distress caused by negative self-beliefs.  The 
study will help us to plan further research into understanding the emotional impact of 
psychosis and help to develop therapies for people who are trying to come to terms with their 
experience of psychosis. 
 
What is psychosis? 
Psychosis involves having unusual experiences which may include hearing voices when there 
is no-one there, or seeing and feeling things that other people do not. Individuals may also 
hold strong beliefs that are not shared by others. However, everyone's experience is different 
and unique. 
 
What is Acceptance and Commitment Therapy? 
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Acceptance and Commitment Therapy is a talking therapy that aims to help people to be fully 
aware of your here-and-now experience, with an attitude of openness and curiosity. It is hoped 
that this will help reduce the impact of painful thoughts and feelings. Acceptance and 
Commitment Therapy also aims to help people take effective action that is conscious and 
deliberate, rather than impulsive. It is hoped that this will allow people to be motivated, guided, 
and inspired by the things that they value in life. 
 
Why have I been asked to take part? 
You have been referred to us by a member of the mental health team responsible for your 
care (e.g. Consultant Psychiatrist, Clinical Psychologist or CPN) and have expressed an 
interest in participating in the research.  
 
Do I have to take part? 
No. It is your choice whether or not to take part in the study. If you decide to take part you will 
be given this information sheet to keep and be asked to sign a consent form. The consent form 
is a way of making sure you know what you have agreed to. If you decide to take part, you are 
still free to withdraw at any time without this affecting your care either now or in the future. 
 
What will happen next? 
After reading this information sheet and having your questions answered by the researcher, if 
you decide to take part in the study the researcher will arrange to meet with you again.  At this 
next meeting with the researcher, they will assist you to complete four questionnaires. 
Importantly, there are no right or wrong answers. It is your perspective and experience that is 
important. This meeting will last approximately 1 to 1 ½ hours. Following this, you will be 
allocated at random to either Acceptance and Commitment Therapy intervention or a Control 
group.  
The researcher will then arrange to meet you for a final time to complete some additional 
questionnaires and complete either the Acceptance and Commitment Therapy intervention or 
the Control intervention. If you are in the Control group you will do a task with the researcher 
that involves making patterns out of blocks. This second session will take about an hour. 
 
 
The people who receive the brief Acceptance and Commitment Therapy intervention will be 
asked if the session can be recorded on a digital audio recorder.  This is to ensure that the 
therapist is doing the treatment correctly. These recordings are confidential and will be stored 
securely and will only be listened to by professional staff involved in the study, after which they 
would be destroyed. They can also be made available for you to listen to if you wish (some 
people find this helpful). 
 
What are the possible risks of taking part? 
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It is possible that our meetings may cover topics that are difficult or distressing for you to talk 
about. However, if you do not want to continue you can end the interview at anytime. Your 
key-worker will know about our meeting times and either they or a duty worker will be 
available. This means that afterwards you can speak with me or someone who knows you 
about your experience of participating. 
 
What are the possible benefits of taking part? 
The information we learn from this study will help us plan future research into the experience 
of psychosis and help to develop talking therapies for people who are trying to come to terms 
with their experience of psychosis. Those allocated at random to the Acceptance and 
Commitment Therapy intervention, may also find taking part in the task exploring thoughts 
about themselves helpful in managing similar thoughts in the future.  
 
Will my taking part in the study be kept confidential? 
Yes. The information that you provide will be treated confidentially. Your name or other 
identifying information will not appear in any reports. All recordings will be stored on a 
password-protected computer with permission from you and will be destroyed once they have 
been listened to. Your GP will be informed that you are taking part in the study.   The clinical 
team responsible for your care will be provided with a summary of the assessment measures 
you complete. 
If information that you share with me leads me to believe that you might be putting the safety 
of yourself or others at risk, I may be required to tell other people involved in your care 
(Psychiatrist, Psychologist, CPN etc). I will always notify you if I am going to do this and 
explain why I feel it is important for me to share the information.  
 
What will happen to the results of the research study? 
I will provide you with a summary of the results of the study. The final results and conclusions 
of the study will be published in a scientific journal and will form part of my qualification in 
Clinical Psychology. Your name or any identifiable information unique to you will not be 
included in any publication, it will only describe what happened to the groups of people who 
received different types of treatment. 
 
Who is organising and funding the research? 
The University of Glasgow and NHS Greater Glasgow & Clyde will organise and fund the 
research.  
 
 
Who has reviewed the study?  
 
The study has been reviewed by the University of Glasgow to ensure that it meets standards 
of scientific conduct. It has also been reviewed by the West of Scotland Ethics Committee and 
the sponsor NHS Greater Glasgow and Clyde to ensure that it meets standards of ethical 
conduct.  
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What if I want to make a complaint? 
If you want to complain about any aspect of this study, please contact Dr Ross White, Section 
of Psychological Medicine, Gartnavel Royal Hospital, 1st Floor, Admin Building, University of 
Glasgow, Glasgow G12 0XH, Tel: 0141 2113918. 
 
Independent Contact: If you would like to discuss the study with someone who knows about 
the study but is not involved in the research please contact:  
Professor Andrew Gumley Tel: 0141 211 3927. 
 
Details about the NHS complaints procedure can also be found at:  
Tel: 0141 201 4500e-mail: complaints@ggc.scot.nhs.uk 
 
Thank you very much for reading this information and for any further involvement you 
may have in the study. 
 
 
 
 
 
 
 
 
 
 
CONSENT FORM 
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A study of experiences of difficult emotions and low mood in Psychosis 
 
Name of Researcher:   Rebecca Frost  
Contact Address:   Department of Psychological Medicine  
Academic Centre  
Gartnavel Royal Hospital  
1055 Great Western Road  
Glasgow G12 0XH  
Please Tick   
 
1. I confirm that I have read and understood the participant information sheet about the 
study (Version 4, 9th August 2011) 
 
2. I have had the opportunity to consider the information, ask questions about the study, 
and have had these answered satisfactorily.  
 
3. I understand that my participation in the study is voluntary and that I am free to 
withdraw from the study at any time, without giving any reason, and without my 
medical care or legal rights being affected.  
 
4. I understand that it may be difficult or upsetting to talk about my experiences of 
psychosis, and that I will have access to professional support if this is required.  
 
5. I understand that I will be required to meet with the researcher on two separate 
occasions, for approximately one hour.  
 
6. I understand that my second interview may be recorded on an audio-recording device, 
for purposes outlined in the participant information sheet (Version 4, 9th August 2011). 
 
7. I give consent for the research team to contact the doctor involved in my care to confirm 
my diagnosis.  
 
8. I give consent for the researcher, to contact my key-worker at any point during my 
participation in the research.  
 
9. I agree for my GP to be informed of my participation in the above study.  
 
10. I give consent for a summary of the assessment measures I complete to be shared with 
the clinical team responsible for my care.  
 
11.  I agree to participate in the above study.  
 
 
 
 
 
 
 
Name of Participant    Date    Signature  
 
            
 
 
Name of Person Taking Consent  Date   Signature  
 
(if different from researcher)  
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Thank you for taking part in the study. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
RESEARCH STUDY 
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Experiences of difficult emotions and low 
mood in Psychosis 
 
 
 
 
 
 
 
 
 
 
Interested in finding out more?   Get in touch! To find out more information or to be referred to take part 
in this study, please contact a member of your mental health team (e.g. psychiatrist, CPN) who will 
provide you with more information.  
 
 
 
Appendix 2.4: Client Questionnaire 
Client Satisfaction Questionnaire 
Please help by answering some questions about the brief intervention you received as 
part of your participation in research. Your feedback is anonymous and your honest 
opinion is important, whether it is positive or negative. Please answer all of the 
questions.  
 Have you experienced an episode of Psychosis?   
 Have you experienced low mood or difficult emotions? 
 Are you aged 18 or above?      
If yes, then you might be interested in taking part.                                                                         What is the research about? 
The research is being carried out to find out more about psychosis and how it 
may affect emotions and mood. It will also help us to improve our 
understanding of the emotional impact of psychosis and help to develop 
therapies for people who have experienced psychosis. 
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Thank you very much for your help. 
 
PLEASE CIRCLE YOUR ANSWER 
 
1. Has the brief intervention you received been helpful? 
1 2 3 4 
No, definitively not No, not really Yes, generally Yes, definitively 
 
2. Has the brief intervention you received helped you to deal more effectively with any 
problems? 
1 2 3 4 
No, definitively not No, not really Yes, generally Yes, definitively 
 
3. If a friend were in need ofsimilar help, would you recommend the intervention to 
him/her? 
4 3 2 1 
Yes, it helped a great deal Yes, it  helped somewhat No ,it really didn’t help No, it seemed to make things 
worse 
 
4. Overall,  how satisfied are you with the brief intervention you received? 
4 3 2 1 
Very satisfied Mostly satisfied Mildly dissatisfied Quite dissatisfied 
 
5. If you were to seek help again, would you consider engaging in a similar type of 
intervention/treatment? 
1 2 3 4 
No, definitively not No, not really Yes, generally Yes, definitively 
 
Appendix 2.5: Measurement of believability and distress, cognitive defusion exercise 
and control exercise. 
Outline for session 2 DEFUSION 
Welcome back 
1) ISS :identification of negative self thought.  
Rating of distress and believability 
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1 2 3 4 5 6 7 8 9 10 
 
2) Getting distance between you and your thoughts. 
Sometimes we can get caught up in our thoughts. It can be helpful to learn how to notice our thoughts 
and let go of them rather than getting caught up in them.  That will be our focus for today. 
• Words can alter how we feel e.g “Dinners ready!” would probably make you feel a particular 
way, whereas the words “You have a dentist appointment tomorrow” would maybe make you 
feel something a bit different! 
• Throughout life we pair up words and phrases with particular experiences, objects and 
situations. Certain phrases become so familiar that we complete them without having to stop 
and think about them e.g. Twinkle twinkle little.......................Humpty dumpty sat on a 
............................I am................................You are..................................... 
• Sometimes when we feel we are struggling,  we are having these thoughts. 
• Sometimes we can fall into the habit of using particular words and phrases to describe 
ourselves. We pay so much attention to the story that we think describes us that we end up 
getting lost in it. We regard the language we use to describe our memories of ourselves (who 
we are, what we have done and what other people think about us) as being facts.  
 
Do you remember a birthday from when you were younger?  
• Did you have a cake?  
• Who was there at the time?  
• What age were you?  
• Can you tell me anything else that you remember about that day? 
• Can you tell me what happened 17 days before that? 
• Can you tell me when happened 21 days after that? 
We are not actually that great a historian of our own lives; we tend to remember only certain things in 
our lives, this provides us with stories about ourselves. And it is these details that give rise to the 
stories we have about our lives. These “stories” can powerfully influence how we feel, even though 
they may not be that accurate. 
Now were going to do an exercise that some people find helpful to get some distance between 
themselves and the unhelpful thoughts or words they have about themselves..... 
3) Intervention 
We are going to use the statement we spoke about earlier (on the ISS). I want you to think about that 
and buy into it for a few seconds (10secs). Now let’s type it on the computer screen. Let me help you 
to…. 
1. Change the font 
2. Change the colour 
3. Change the size 
4. Underline it / make it bold 
5. Write/Read the sentence backwards 
6. Say the phrase in a foreign accent or funny voice 
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7. Discuss the spell checker / thought checker concept 
What is it like seeing the thought about yourself on the computer screen? 
 This exercise is about helping us to notice the “stories’ that we use to describe ourselves. With this 
exercise we are getting back to the idea that these stories are not necessarily facts they are actually a 
collection of sounds. What we are practicing is being with those sounds rather than getting caught up 
reacting to the meaning we attach to the story. 
Getting space form our thoughts helps us to stay in the ‘here and now’ and gives us the energy to 
focus on what’s important to us. 
Repeat Rating of distress and believability 
1 2 3 4 5 6 7 8 9 10 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outline for session 2 CONTROL 
Welcome back 
4) ISS :identification of negative self thought.  
Rating of distress and believability 
1 2 3 4 5 6 7 8 9 10 
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5) Block design task (30mins) 
• Now we are going to do a puzzle together. This puzzle is not part of an assessment and you are 
not being tested or scored on this. It is just a task we can do tighter to provide us with some 
time-out before we think about the negative thought again. 
• I have here some blocks with two colours of them. I am going to put these blocks together to 
make a pattern. Watch me.  Now you try it and see if you can make one like mine. Ok, great, 
let’s try a new one.  
• Again I am going to put the block together to make a design. Why don’t you try to make this 
one? Great. 
• Ok, I have here a book with different designs. Each design gets a bit more difficult. Perhaps we 
could work together to see if we can make some of these designs?  Ok? So lets put the blocks 
together to try to make it look like this picture here?  
 
         3)  Repeat Rating of distress and believability 
1 2 3 4 5 6 7 8 9 10 
 
 
       
 
 
 
 
 
 
Appendix 2.6: Frequencies and percentage of response to client satisfaction 
questionnaire 
 
Question 1 
 
No, definitely not 
 
0 
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Has the brief intervention been helpful? 
  
No, not really 0 
Yes, generally 3 (60%) 
Yes, definitely 
 
2 (40%) 
Question 2 
Has the brief intervention you received 
helped you to deal more effectively with 
any problems? 
No, definitely not 0 
No, not really 2 (40%) 
Yes, generally 1 (20%) 
Yes, definitely 
 
2 (40%) 
Question 3 
If a friend were in need or similar help, 
would you recommend the intervention? 
Yes, it helped a great deal 2 (40%) 
Yes, it helped somewhat 3 (60%) 
No, it didn’t really help 0 (0%) 
No, it seemed to make things worse 
 
0 (0%) 
Question 4 
How satisfied were you with the brief 
intervention you received? 
Very satisfied 3 (60%) 
Mostly satisfied 1 (20%) 
Mildly dissatisfied 1 (20%) 
Quite dissatisfied 
 
0 (0%) 
Question 5 
Would you consider engaging in a 
similar type of intervention? 
No, definitely not 0 (0%) 
No, not really 0 (0%) 
Yes, generally 3 (60%) 
Yes,  definitely 2 (40%) 
 
 
 
 
Appendix 2.7: Acceptance and Action Questionnaire-II 
AAQ-II 
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Below you will find a list of statements. Please rate how true each statement is for you 
by circling a number next to it. Use the scale below to make your choice. 
1 2 3 4 5 6 7 
never 
true 
very seldom 
true 
seldom 
true 
sometimes 
true 
frequently 
true 
almost 
always 
true 
always 
true  
1. My painful experiences and memories make it difficult for me 
to live a life that I would value. 
1 2 3 4 5 6 7 
2. I’m afraid of my feelings. 1 2 3 4 5 6 7 
3. I worry about not being able to control my worries and feelings. 1 2 3 4 5 6 7 
4. My painful memories prevent me from having a fulfilling life. 1 2 3 4 5 6 7 
5. Emotions cause problems in my life. 1 2 3 4 5 6 7 
6. 
It seems like most people are handling their lives better than I 
am. 
1 2 3 4 5 6 7 
7. Worries get in the way of my success. 1 2 3 4 5 6 7 
 
This is a one-factor measure of psychological inflexibility, or experiential 
avoidance. Score the scale by summing the seven items. Higher scores equal 
greater levels of psychological inflexibility. 
 
 
 
 
 
 
 
Appendix 2.8: Difficulties in Emotion Regulation Scale 
  
Difficulties in Emotion Regulation Scale (DERS) 
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Please indicate how often the following 36 statements apply to you by writing the appropriate number 
from the scale above (1 – 5) in the box alongside each item. 
1 2 3 4 5 
Almost never Sometimes About half the time Most of the time Almost always 
(0-10%) (11-35%) (36-65%) (66-90%) (91-100%) 
1 I am clear about my feelings (R)  
2 I pay attention to how I feel (R)  
3 I experience my emotions as overwhelming and out of control  
4 I have no idea how I am feeling  
5 I have difficulty making sense out of my feelings  
6 I am attentive to my feelings (R)  
7 I know exactly how I am feeling (R)  
8 I care about what I am feeling (R)  
9 I am confused about how I feel  
10 When I’m upset, I acknowledge my emotions (R)  
11 When I’m upset, I become angry with myself for feeling that way  
12 When I’m upset, I become embarrassed for feeling that way  
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13 When I’m upset, I have difficulty getting work done  
14 When I’m upset, I become out of control  
15 When I’m upset, I believe that I will remain that way for a long time  
16 When I’m upset, I believe that I’ll end up feeling very depressed  
17 When I’m upset, I believe that my feelings are valid and important (R)  
18 When I’m upset, I have difficulty focusing on other things  
19 When I’m upset, I feel out of control  
20 When I’m upset, I can still get things done (R)  
21 When I’m upset, I feel ashamed with myself for feeling that way  
22 When I’m upset, I know that I can find a way to eventually feel better (R)  
23 When I’m upset, I feel like I am weak  
24 When I’m upset, I feel like I can remain in control of my behaviours (R)  
25 When I’m upset, I feel guilty for feeling that way  
26 When I’m upset, I have difficulty concentrating  
28 When I ’m upset,  I  bel ieve that there is  nothing I  can do to make myself  feel better 
29 When I’m upset, I become irritated with myself for feeling that way  
30 When I’m upset, I start to feel very bad about myself  
31 When I’m upset, I believe that wallowing in it is all I can do  
32 When I’m upset, I lose control over my behaviours  
33 When I’m upset, I have difficulty thinking about anything else  
34 When I’m upset, I take time to figure out what I’m really feeling (R)  
35 When I’m upset, it takes me a long time to feel better  
36 When I’m upset, my emotions feel overwhelming.
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Appendix 2.9: Major Research Project Proposal 
Experiential avoidance in Psychosis:  Associations with emotion dysregulation and depression? 
Abstract 
Background: Cognitive interventions for psychosis have focussed on modifying the content of 
cognitive events. However, these interventions do not place specific emphasis on exploring the 
individual’s willingness to accept these cognitive experiences. Acceptance and Commitment Therapy 
places specific emphasis on the role of avoidance of experiences (such as cognitions) in 
psychopathology. Further exploration of this ‘experiential avoidance’ in psychosis may provide more 
insight into how individuals regulate emotion associated with distressing cognitive events (e.g. 
worries, beliefs, memories).  
Aims: The aim of the study is to determine if experiential avoidance is associated with depression 
and emotional dysregulation following psychosis. The study will also examine the acceptability of 
ACT intervention for psychosis by comparing a brief one-session intervention of ACT with a control 
condition to see if experimentally manipulating experiential avoidance reduces distress associated 
with negative self-cognitions. 
Method: A sample of 30 individuals experiencing psychosis will be recruited. After providing 
informed consent, participants will complete measures of psychiatric symptoms, depression, 
experiential avoidance, emotion dysregulation, internalised shame, as well as provide subjective 
ratings of the distress and believability of negative self-cognitions. Participants will be randomised to 
either a 30minute brief ACT intervention aimed at reducing experiential avoidance or a control 
condition. 
Applications: This study has the potential to contribute to existing theory and research focused on 
developing conceptualisations of experiential avoidance in psychosis. As well as add to the 
development of psychological therapies that facilitate a reduction in experiential avoidance and 
increase skills in emotion regulation for individuals experiencing distress in psychosis. 
 
Introduction 
The primary aim of the study is to determine if experiential avoidance is associated with emotion 
regulation difficulties and depression in individuals with psychosis. Some existing cognitive therapies 
and interventions for psychosis have focussed on modifying the content of appraisals made about  
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symptoms that the individual may be experiencing. However these interventions place less emphasis 
on the individual’s relationship with internal mental events and how this may be conceptualised 
within the formation and maintenance of the psychotic experience. Acceptance-based therapeutic 
approaches do not attempt to modify symptom occurrence,instead it is hypothesised that 
reductions in distress are achieved by altering the individual’s relationship with the symptoms by 
reducing the emotional and experiential avoidance maintaining distress (Gaudiano et al. 2010).  
Bach and Hayes (2002) conducted the first study exploring this hypothesis, randomly assigning 
psychotic in-patients to Acceptance and Commitment Therapy (ACT) or treatment as usual. ACT 
produced lower symptom believability and reduced rehospitalisation. This was replicated by 
Gaudiano and Herbert (2006) who conducted a randomised control trial of ACT in an in-patient 
population with psychosis. ACT produced greater improvements in symptom related distress, 
affective symptoms and social impairment. Further exploration of the acceptability of ACT 
interventions and the role of key treatment targets of ACT (such as experiential avoidance) in 
psychosis may provide more insight in to how individuals can better regulate emotion and adapt to 
symptom experience. This may contribute to the development of psychological therapies that 
facilitate a reduction in processes such as experiential avoidance and increase skills in emotion 
regulation for individuals experiencing psychosis.  
The conceptualisation of emotion regulation  
Emotional regulation has been investigated as a mechanism underlying various forms of 
psychopathology. Despite this, conceptualisations of emotion regulation are broad (Gratz&Tull, 
2010). For example, emotion regulation has been equated with the control and reduction of 
negative emotions (Kopp, 1989: Zeaman&Garder 1996) thus describing negative emotion as a sign of 
emotional dysregulation. However, more recent research indicates that control or suppression of 
unwanted internal experiences may actually increase the frequency, severity and accessibility of 
these experiences (Hayes et al 2006; Gaudiano et al 2006). These paradoxical effects indicate a 
functionality of emotional experience, suggesting that adaptive emotion regulation may involve the 
ability to maintain awareness and understanding of emotional experience rather than directly 
controlling the emotions themselves. For the purpose of this study emotion regulation will be 
defined as, adaptive ways of responding to emotional distress rather than attempts to control or 
dampen down emotional arousal in general (Gratz&Tull 2010). 
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Emotion regulation and psychosis 
The emotional experiences of individuals who experience psychosis has, until recently, been a 
neglected area of research (Livingston et al. 2009). This may be as a result of a historical divide 
between the neuroses and psychosis (Freeman &Garety, 2003). However, the role of emotion in 
psychosis is now being increasingly recognised.  Livingston et al (2009) suggest there is an interaction 
between emotional dysfunction and psychotic symptoms. In order to regulate emotions, individuals 
who develop psychosis may rely on suppression and the directing of the individuals resources 
towards internal regulation. Therefore the role of emotion dysregulation may be important in the 
formation and maintenance of psychosis (Livingston et al, 2009). Furthermore, there is an 
established evidence base indicating elevated levels of anxiety and depression in individuals who 
have experienced psychosis (Freeman &Garety 2003). These elevated levels of anxiety and 
depression are also evident prior to the development of psychosis (Neale et al. 1998). 
Depression in psychosis 
Depressive symptoms have been found to accompany psychosis as well as develop following the 
psychotic episode (Birchwood, 2000; Kuipers, 2005). Rates of depression are 50% following a first 
episode of psychosis and 33% in established psychosis (Whitehead et al., 2002). It is now becoming 
clear that the experience of depression is one of the major factors contributing to poorer quality of 
life amongst individuals with psychotic disorders generally (Saarni et al., 2010) and schizophrenia 
specifically (Meijer et al., 2009; Narvaez et al., 2008)  
Birchwood et al. (2000) reported that individuals with depression and lower self-esteem had 
auditory hallucinations of greater severity, more intensely negative in content and were more 
distressed by them. In addition, individuals with elevated depression had more negative evaluations 
about themselves and others, had persecutory delusions of greater severity and were more pre-
occupied and distressed by them.  
The themes of loss, shame, entrapment and humiliation appear to be important for the emergence 
of depression in psychosis (Rook & Birchwood, 1998). A study by Iqbal et al. (2000) reported that the 
meaning given to the psychotic episode and cognitive appraisals of psychosis involving loss of social 
role and shame predicted those who later developed post psychotic depression. Depression in non-
psychosis populations has been associated with both internal (Tagney et al. 1995) and external 
shame (Allan et al, 1994; Gilbert et al, 1996). Internalised shame refers to negative cognitions and 
feelings of our own  
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attributes, personality and behaviour. External shame relates to evaluations of those aspects we 
believe others would reject or attack (Gilbert, 2000). Vikan et al (2010) found that higher levels of 
internalised shame were present in depression than anxiety. Comparatively little research to date 
has investigated the role of internalised shame in depression experienced by individuals with 
psychosis.  
Experiential avoidance 
Experiential avoidance can be described as an attempt or desire to suppress unwanted internal 
experiences, such as emotions, thoughts, and bodily sensations. Evidence suggests that an 
unwillingness to stay in contact with internal experiences can reinforce a non-accepting and 
judgmental stance towards emotion experience. Therefore, treatments that focus on teaching 
individuals to avoid or control their emotions may inadvertently be associated with the paradoxical 
effects described above (Gratz et al. 2010).   
There is evidence indicating an association between experiential avoidance and emotion regulation 
difficulties. For example Sloan et al. (2004) found that participants assessed as high in experiential 
avoidance reported greater emotional experience to both unpleasant and pleasant stimuli compared 
to participants assessed as low in experiential avoidance. Tull et al. (2007) reported that experiential 
avoidance or the active suppression of emotional expression was associated with heightened 
emotion dysregulation, as measured by the Difficulties in Emotion Regulation Scale (DERS), in 
individuals with PTSD. Kahn and Garrison (2009) found depression and anxious arousal were 
associated with lessened emotional self-disclosure as mediated by avoidance of emotional 
expression.  Furthermore, increased experiential avoidance has been found to correlate with anxiety 
sensitivity (Berman et al. 2010) and uncued panic attacks (Tull et al. 2008). 
Acceptance and Commitment Therapy  
Acceptance and Commitment Therapy (ACT) encourages individuals to interact with negative 
thoughts, feelings and emotions mindfully to reduce experiential avoidance while simultaneously 
working towards the pursuit of valued behaviours (Gaudiano et al 2006). ACT identifies the use of 
clinical strategies including cognitive defusion,self as context, self de-stigmatisation to promote 
moving towards value based goals in reducing distress in psychosis (Bach & Hayes, 2002). An ACT 
consistent approach would propose that distress can be reduced not by trying to directly focus on 
the symptom, but instead by exploring the functional context in which these symptoms are 
experienced.  
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When considering the evidence discussed above in relation to emotion regulation difficulties and 
experiential avoidance in individuals experiencing psychosis; the use of ACT consistent interventions 
aimed at reducing experiential avoidance and increasing acceptance of emotions may be effective in 
reducing distress.  This is supported by evidence that the believability of symptoms has been found 
to be a mediator of distress in psychosis (Gaudiano et al 2010).  Masuda et al (2004) reported that a 
one session cognitive defusion technique reduced both the discomfort and believability of a self-
relevant negative to a significantly greater extent than did a thought suppression and distraction 
condition in undergraduate students.  
The current study 
Based on the above literature review, the current study aims to investigate further the efficacy an 
ACT intervention for psychosis by: 
iii. Identifying if experiential avoidance is correlated with emotion regulation and depression 
in psychosis. 
iv. Investigating the role of experiential avoidance in distress associated with negative self-
cognitions in psychosis in a randomised brief intervention study. The effects of a cognitive 
defusion exercise and a neutral cognitive distraction task on subjective units of distress 
associated with negative self-cognitions will be investigated. 
 
Hypotheses 
1. Higher levels of depression will be associated with increased experiential avoidance and greater 
emotion regulation difficulties. 
2a. The use of a session of ACT will be acceptable to individuals with psychosis who are experiencing 
depression, as measured by a satisfaction questionnaire. 
2b. There will be differences in subjective units of distress associated with negative self-cognitions 
between intervention groups following a brief cognitive defusion exercise or a neutral cognitive 
distraction task: Distress reported will be higher in the distraction task group compared to the 
cognitive defusion group. 
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Plan of investigation 
Participants 
Inclusion Criteria 
Participants will be aged between 18-65 years old. They will be required to meet the ICD-10 (WHO, 
1992) criteria for Schizophrenia, Schizoaffective or Schizotypal disorders or Bipolar disorder with 
psychotic features. Participants who are receiving or have received psychological therapy in the past 
will not be excluded from the study.  
Exclusion Criteria 
Individuals who have a learning disability, brain injury, organic brain disease, or substance use 
disorder (as stipulated by ICD-10 criteria) will not be included in the study. Individuals who are 
adjudged by the clinical team repsonible for their care to lack the capacity to consent to 
participation in research will be excluded from the study.  
Participants will be required to provide informed consent to be included in the study and therefore 
must speak and understand English. Individuals experiencing acute distress or active suicidality, as 
judged by the clinical team responsible for their care, will not be included in the study. 
Recruitment 
Participants will be recruited from Community Mental Health Teams (CMHT) in the Greater Glasgow 
and Clyde area. Presentations to CMHT staff will be conducted to provide information about the 
study aims and the referral process.  Potential participants will be identified and first approachedby 
CMHT staff who will provide participants with a participant information sheet and a reply slip for 
them to complete should they consent for  their details to be passed onto the main researcher. 
Potential participants will be identified by CMHT staff on the basis that they are presenting with 
depression following an episode of psychosis. It is hoped that 30 participants will be recruited. 
Those who wish to participate will then be asked to provide written and informed consent. If 
consent is provided the individual will then be invited to attend two sessions at the referring CMHT. 
The case manager will be informed of the participants consent to participant. If the participant’s 
become distressed during the sessions the case manager or duty staff will be informed as soon as 
possible.   
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Measures 
ThePositive and negative symptoms of Schizophrenia Scale (PANSS) (Kay &Opler 1987). The PANSS is 
a 30 item clinician rated scale used to assess the presence and severity of psychotic 
psychopathology. The scale assesses both positive (delusions and hallucinations) and negative 
symptoms (emotional withdrawal and blunted affect) as well as global psychopathology.The PANSS 
reports good inter-rater reliability and validity (Bell, Milstein, Beam-Goulet, Lysaker&Cicchetti, 1992; 
Kay, Opler&Lindenmayer, 1988).  
Difficulties in Emotion Regulation Scale (DERS) Gratz and Roemer (2004). The DERS is a 36 item self 
report measure that assesses an individuals’ typical levels of emotion regulation difficulties across 
specific dimensions of emotion regulation. Individuals are asked to rate how often a statement 
applies to them ranging from 1 to 5, with 1 being “almost never” and 5 being “almost always”.  The 
subscale of emotion regulation are (a) non-acceptance of emotional responses; (b) difficulties 
engaging in goal directed behaviours when distressed; (c) difficulties controlling impulsive behaviour 
when distressed; (d) lack of emotional awareness; (e) limited access to emotion regulation strategies 
perceived as effective and (f) lack of emotional clarity. The DERS score provides an overall score as 
well as subscale scores related to greater difficulties in emotion regulation. The DERS has been 
found to have high internal consistency with both clinical (Gratz et al, 2008; Fox et al, 2007) and non-
clinical samples (Gratz& Roemer, 2004; Johnson et al, 2008). 
The Beck Depression Inventory – Second Edition (BDI- II),Beck, Steer & Brown (1996). The BDI-II is a 
widely used measure of depressive symptoms and is considered a valid and reliable instrument for 
use depression screening in general and clinical populations (Beck et al, 1996). The BDI-II yields a 
single score with standardized ranges indicating no/minimal depressive symptoms to mild, moderate 
or severe depressive symptoms. Items in the BDI-II reflect cognitive (C), affective (A), and somatic (S) 
components of depression. 
The Internalised Shame Scale (ISS) Cook (1996). The ISS assesses feelings of inferiority, 
worthlessness, inadequacy, and alienation and can be used as a screening tool to assess an 
individuals specific feelings of shame that are involved in the presenting problem(Cook, 1994, 2001).  
The ISS requires individuals to rate each 30 items on a five point Likert scale ranging from 0 
(“Never”) to 4 (“Almost Always”). There are 24 negatively worded items that measure shame and 6 
items that measure self-esteem. The ISS scales demonstrate high temporal stability and high internal 
consistency (Rosario & White 2006).  
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Acceptance& Action Questionnaire (AAQ-II), Bond et al (2010). The AAQ-II is a 10-item revision of the 
original 9-item AAQ (Hayes, 2000). It is a self report measure of experiential avoidance, negative 
evaluations of internal experience and psychological acceptance; also known as ‘‘psychological 
flexibility,’’ which is a core construct of the ACT model of psychopathology (Hayes et al., 2006). The 
AAQ-II has been shown to have good convergent, validity (Bond et al., 2007). Higher scores on the 
AAQ-II indicate greater psychological flexibility, a therefore lower vulnerability to developing 
pathology.  
Client Satisfaction Questionnaire: A 5 item self-administered questionnaire, based on the Client 
Satisfaction Questionnire-8 item version (CSQ-8) by Attkisson and Greenfield (2004) will be given to 
individuals randomised to ACT. The items enquire about the participants’ opinions about the 
intervention they received. Answers are based on a four point scale (1= No, definitively not  2= No, 
not really 3= Yes, generally 4= Yes, definitively) and examples of question include “Has the brief 
intervention you received helped you to deal more effectively with any problems?” and “If you were 
to seek help again, would you consider engaging in a similar type of intervention/treatment?”. The 
questionnaire score ranges from 5 to 20, with higher values indicating higher satisfaction. 
Idiographic measures of distress and believability associated with the negative self-cognitions 
identified through the ISS, will be assessed before and after the brief intervention. Scales similar to 
those used by Bach and Hayes (2002) will be administered to assess believability and distress 
associated with positive symptoms of psychosis. Participants will be asked “When considering the 
negative self thought how would you rate your distress on a scale of 1-10? (1 being no distress and 
10 being most distressed)” and  “How believable is the negative self thought on a scale of 1-10? (1 
not believable and 10 being very believable)”. 
Research design 
Phase 1.Investigating the association between experiential avoidance and emotion regulation 
difficulties in psychosis 
A cross sectional questionnaire study with descriptive and correlational analyses will be employed. 
The independent variables will be experiential avoidance and emotion regulation and the dependent 
variable will be depression.  
Phase 2.Investigating the role of experiential avoidance on distress in psychosis 
 
 
135 
 
The principle aim of phase 2 is to investigate whether a brief one session ACT intervention aimed at 
reducing experiential avoidance will reduce distress associated with negative self cognitions. 
Participants from Phase 1 will be given the opportunity to participate in the phase 2 of the study. 
These participants will be randomly assigned to either cognitive defusion exercise, aimed at reducing 
experiential avoidance or a control condition involving a block design task that will serve as a neutral 
cognitive distraction task. 
Research procedures 
Phase 1 (Session 1) – Assessment session (60-80mins): This will include orientation, rapport-building 
and completion of ThePositive and negative symptoms of Schizophrenia Scale (PANSS) conducted by 
the researcher. The Acceptance& Action Questionnaire (AAQ-II), The Beck Depression Inventory – 
Second Edition (BDI-II) and the Difficulties in Emotion Regulation Scale (DERS) are self-report 
measures that will be completed by the participant during the session. 
Following the completion of session 1, the details of participants wishing to participate in phase 2 
will be passed to Dr Ross White who will then undertake computerized randomization using a 
predetermined schedule of permuted blocks of random size. Participants will be randomised to 
either:  
• A one session ACT intervention for internalised shame in psychosis aimed at decreasing 
levels of experiential avoidance. 
• A neutral cognitive distraction task that maintains pre-existing levels of experiential 
avoidance. 
 
Phase 2 (Session 2) – Participants will complete the Internalised Shame Scale (ISS) to assess and 
identify individual negative self cognitions. Participants will then rate a selected negative self 
cognition (i.e. item on the ISS that they scored highly on) for: a) Distress and b) Believability using 
the idiographic measures described earlier. The participants will then complete 30 minutes of either 
the ACT intervention or the block design task with the chief investigator. Participants will then re-
rate the negative self cognition for subjective distress. Participants in the intervention condition will 
also complete a satisfaction questionnaire. At the end of each session participants will be given time 
in order to monitor and ameliorate any distress arising from the meeting. Session 2 will be recorded 
by the Chief Investigator and independently rated for adherence to treatment modality. 
 
Individuals randomised to the ACT intervention will be asked to complete the Client Satisfaction 
Questionnaire anonymously and return it in a stamped addressed envelope to the researcher. These  
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individuals will be offered a copy of the recording of their brief intervention session to consolidate 
their learning. When the study is complete, all participants will be provided with a written summary 
of findings.  
 
Justification of sample size 
Power calculations  
Phase 1: White et al. (in submission) examined the association between experiential avoidance and 
depression in a sample of people with psychosis. A correlation of r = -0.55 was reported. GPower 
v3.1.2, (Erdfelder et al. 1996) a general power analysis program, was used to conduct a power 
calculation for bivariate correlational design (based on the aforementioned correlation of r = -0.55 
obtained by White et al., in submission), with power set at 0.80 and alpha set at 0.05. This analysis 
indicated that a sample size of 19 would have a power of 0.82.  Although a minimum sample size of 
19 is indicated, it is hoped that 30 participants will be recruited to increase power. 
Phase 2: Masuda et al (2004) compared the effect of cognitive defusion on distress with self relevant 
negative thoughts compared to a distraction task. These authors reported the treatment and control 
means of a small sample but did not report the effect size or standard deviations necessary to 
calculate the power of the study. As such, Phase 2 of the current trial will determine power levels 
useful for future studies of this type of brief one-session intervention. Sensitivity analyses were 
conducted to highlight a range of required effect sizes for Phase 2 given alpha = 0.05, power= 0.80 
with a sample size of 19 and 30 respectively. 
 
Sample 
size 19 
Power 0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95 
Effect Size 0.47 0.49 0.51 0.53 0.55 0.58 0.61 0.66 
 
Sample 
size 30 
Power 0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95 
Effect Size 0.38 0.40 0.42 0.44 0.47 0.49 0.52 0.56 
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Settings and equipment 
All sessions will be conducted on the premises of the CMHT (NHS Greater Glasgow & Clyde) where 
the participant is case managed. The following equipment will be required:  
• The PANSS, AAQ-II, DERS, ISS and BDI-II are required for administration with each 
participant, in adherence with copyright law. 
• A recording device for recording of session 2. 
 
Statistical analysis 
In the analysis of Phase 1, a cross-sectional questionnaire design, descriptive and correlational 
analyses will be performed in order to determine if higher levels of depression will be associated 
with increased experiential avoidance and greater emotion regulation difficulties. A linear regression 
analysis will also be conducted to determine how much variance in depression scores (dependent 
variable) is accounted for by the independent variables (experiential avoidance, difficulties with 
emotion regulation, and symptoms of psychosis). 
 In the analysis of Phase 2, the intervention study, parametric or non-parametric between-group 
comparisons will be made to determine whether there are significant differences in levels of distress 
and believability associated with negative self-cognitions between the different arms of the study 
that participants are randomised.  
Health and Safety Issues 
When considering researcher and participant safety, each CMHT used to recruit and provide 
intervention will be reviewed for health and safety legislation. Local policy and procedure will be 
adhered to and arrangements will be overseen by the local field supervisor. Each participant will be 
interviewed individually by the Chief Investigator on the premises of the CMHT the participant is 
case managed. No home visits will be conducted. Both researcher and participant will have access to 
facilities and will be made aware of safety procedures.  The participants will be made aware of their 
right to withdraw from participation at any time. Should it be required, participants will be able to 
access their key worker or duty worker within the CMHT following sessions; this will be facilitated by 
the researcher if required. If a participant presents as very distressed they will be withdrawn from 
the study and their key worker or duty working will be notified immediately. 
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Ethical considerations 
• Ethical approval will be sought from the local Research Ethics Committee.  
• Informed consent will be provided by participants. A participant information sheet and 
consent form will provide details of the study and will require participants to give voluntary, 
written consent. The form will state that participants are consenting voluntarily and can 
withdraw at any time without affecting ongoing or subsequent health care and treatment. 
The researcher will assess capacity to consent. 
• Individuals meeting the inclusion criteria will be assessed for their capacity to provide 
informed consent and therefore insight, symptom severity and distress will also be 
considered. The clinical team responsible for their care will make a clinical judgement as to 
whether they are have sufficient capacity to consent to participate in the research. 
• Individuals will be informed of confidentiality in accordance with NHSGGC policy and 
procedure. 
• Recruiting individuals experiencing depression in psychosis for this study may present risk 
issues as depression has been associated with suicidal behaviour. Therefore, any risk issues 
will be reported by the researcher to the participant’s key-worker or duty worker if required. 
• The current study is exploring distress experienced by participants. If distress is raised during 
participation that requires follow-up, then participants will have access to appropriate 
professional care. The researcher is also experienced in managing distress and assessing risk.  
• Data stored will be anonymised by the removal of identifying details and stored on a 
password protected, encrypted laptop in accordance with NHSGGC data protection policy 
and procedure.  Audio recordings will also be stored on a password protected, encrypted 
laptop and deleted at the end of the study.  
 
Finance 
Item Required  Cost  
Beck Depression Inventory-Second Edition £65 
Internalised Shame Scale £102 
Stationary  £75.14  
TOTAL  £ 242.14 
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Timetable 
Time scale Research Component 
May 2011 Application to ethics. 
Jun-Jul 2011 Presentation to CMHTs 
Aug-Dec 2011 Recruitment and intervention. 
Jan 2012 Data consolidation and analysis.  
Mar 2012 Write-up.  
May 2012 Draft submission.  
Jul 2012 Final submission.  
 
Practical applications 
Prospective benefits of this research include: 
1. Further contributing to existing theory and research focused on developing 
conceptualisations of emotion regulation and experiential avoidance in psychosis. 
2. Assisting in the identification of the psychological needs of service users, requirements of 
service providers and appropriate pathways to service access for individuals with psychosis. 
This is consistent with NHS Quality Improvement Scotland guidelines for schizophrenia (NHS 
Clinical Standards Board for Scotland, 2001). 
3. The completion of a PANSS with patients presenting with psychosis is consistent with the 
Integrated Care Pathway. 
4. Contributing to the development of psychological therapies that facilitate reduced levels of 
depression and increased skills in emotion regulation for individuals experiencing psychosis.  
5. Reducing emotional distress associated with symptoms of psychosis and depression. 
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